{
  "meta": {
    "title": "00084_Late_Night_Pyq_Pyt_Marathon_Pharma_Anesthesia",
    "url": "https://brainandscalpel.vercel.app/00084-late-night-pyq-pyt-marathon-pharma-anesthesia-f9596efa.html",
    "scrapedAt": "2025-11-29T17:25:44.566Z"
  },
  "questions": [
    {
      "id": 574,
      "choices": [
        {
          "id": 2292,
          "text": "<p><span style=\"font-size:12pt;\">Halothane</span></p>"
        },
        {
          "id": 2293,
          "text": "<p><span style=\"font-size:12pt;\">Desflurane</span></p>"
        },
        {
          "id": 2294,
          "text": "<p><span style=\"font-size:12pt;\">Sevoflurane</span></p>"
        },
        {
          "id": 2295,
          "text": "<p><span style=\"font-size:12pt;\">Isoflurane</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Which of the following can be used for induction of anesthesia, maintenance and can be safely used in endotracheal intubation?</span></p>",
      "unique_key": "Q6487621",
      "question_audio": null,
      "question_video": null,
      "map_id": 15764040,
      "difficulty_level": "intermediate",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Sevoflurane</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Sevoflurane is a versatile inhalation anesthetic that can be used for both the induction and maintenance of anesthesia. Its sweet smell makes it suitable for inhalational induction, especially in pediatric patients and others who might find pungent agents unpleasant. Sevoflurane also provides a smooth transition for endotracheal intubation due to its bronchodilatory effects and stable hemodynamic profile. Additionally, its low blood-gas solubility coefficient allows for rapid induction and emergence from anesthesia, which is beneficial in a surgical setting.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;A. Halothane:</strong> While Halothane can be used for induction and maintenance of anesthesia, it has a higher risk of hepatotoxicity and arrhythmias. It is also less commonly used in modern practice compared to Sevoflurane.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;B. Desflurane:</strong> Desflurane is typically used for maintenance rather than induction due to its pungent odor and tendency to cause airway irritation. It also requires a special heated vaporizer due to its high vapor pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;D. Isoflurane</strong>: Isoflurane is primarily used for maintenance of anesthesia rather than induction due to its pungent smell and potential to cause airway irritation. It is less suitable for inhalational induction compared to Sevoflurane.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective :</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Sevoflurane is an ideal agent for both the induction and maintenance of anesthesia and is safe for use during endotracheal intubation due to its favorable properties.</span></p>",
      "correct_choice_id": 2294,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33862,
      "choices": [
        {
          "id": 135286,
          "text": "<p><span style=\"font-size:12.0pt;\">Chlorpromazine</span></p>"
        },
        {
          "id": 135287,
          "text": "<p><span style=\"font-size:12.0pt;\">Clozapine</span></p>"
        },
        {
          "id": 135288,
          "text": "<p><span style=\"font-size:12.0pt;\">Olanzapine</span></p>"
        },
        {
          "id": 135289,
          "text": "<p><span style=\"font-size:12.0pt;\">Ziprasidone</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 40-year-old obese female presented with Schizophrenia. Which of the following antipsychotic drug causes least weight gain?</span> <span style=\"font-size:12.0pt;\">(Fmge Jan 2024)</span></p>",
      "unique_key": "Q5195302",
      "question_audio": null,
      "question_video": null,
      "map_id": 15708914,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. D. Ziprasidone</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Ziprasidone is known to cause less weight gain compared to many other antipsychotics, making it a more suitable option for an obese patient concerned about further weight gain. Clozapine and olanzapine, in particular, are associated with a higher risk of significant weight gain and metabolic changes. Chlorpromazine, while potentially causing weight gain, is generally not as strongly linked to this side effect as clozapine or olanzapine.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A.</strong> <strong>Chlorpromazine:</strong> This is a typical antipsychotic. These drugs can cause weight gain, though chlorpromazine is not as strongly associated with weight gain as some atypical antipsychotics.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B.</strong> <strong>Clozapine:</strong> Clozapine is an atypical antipsychotic known for causing significant weight gain, along with other metabolic effects.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C.</strong> <strong>Olanzapine:</strong> Olanzapine is another atypical antipsychotic that is frequently associated with substantial weight gain and metabolic effects.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Ziprasidone is an atypical antipsychotic associated with a lower risk of weight gain. It is considered more weight-neutral compared to other atypical antipsychotics like clozapine and olanzapine.</span></p>",
      "correct_choice_id": 135289,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7030,
      "choices": [
        {
          "id": 28088,
          "text": "<p><span style=\"color:#333333;font-size:12pt;\">1, 3 and 4 are correct</span></p>"
        },
        {
          "id": 28089,
          "text": "<p><span style=\"color:#333333;font-size:12pt;\">Only 2 is correct</span></p>"
        },
        {
          "id": 28090,
          "text": "<p><span style=\"color:#333333;font-size:12pt;\">1 and 2 are correct</span></p>"
        },
        {
          "id": 28091,
          "text": "<p><span style=\"color:#333333;font-size:12pt;\">All are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"color:#333333;font-size:12pt;\">Chlorpromazine is an antipsychotic drug. It also produces sedation and adverse effects like dry mouth and hypotension. All these actions result due to action on which of the following receptors?(INICET MAY 2024)</span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\">1. D2 and 5HT2 receptors</span></p><p><span style=\"color:#333333;font-size:12pt;\">2. GABA and Beta-adrenergic receptors</span></p><p><span style=\"color:#333333;font-size:12pt;\">3. Muscarinic and alpha-adrenergic receptors</span></p><p><span style=\"color:#333333;font-size:12pt;\">4. H1 receptors</span></p>",
      "unique_key": "Q9412442",
      "question_audio": null,
      "question_video": null,
      "map_id": 15708921,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"color:#333333;font-size:12pt;\"><strong>Ans.&nbsp;A. 1, 3 and 4 are correct</strong></span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Chlorpromazine&nbsp;</strong>is a typical anti-psychotic drug having main mechanism of antipsychotic action as D2 blockade and minor as 5 HT2 blockade. However, it also blocks many other receptors that can result in adverse effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">While chlorpromazine does block H1 receptors causing sedation, it is not the sole receptor responsible for its adverse effects. It must be considered in conjunction with D2, 5HT2, muscarinic, and alpha-adrenergic receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>2. GABA and Beta-adrenergic Receptors:&nbsp;</strong>Chlorpromazine does not primarily act on GABA or beta-adrenergic receptors, hence this option is incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Actions of anti-psychotic drugs</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/17/screenshot-2024-07-17-154713.png\" alt=\"\" width=\"1000\" height=\"352\"></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Reference: - KDT 8<sup>TH</sup>/470-471</strong></span></p>",
      "correct_choice_id": 28088,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4491,
      "choices": [
        {
          "id": 17940,
          "text": "<p><span style=\"font-size:12pt;\">Oxygen saturation</span></p>"
        },
        {
          "id": 17941,
          "text": "<p><span style=\"font-size:12pt;\">Oxygen content of the blood</span></p>"
        },
        {
          "id": 17942,
          "text": "<p><span style=\"font-size:12pt;\">Partial pressure of oxygen</span></p>"
        },
        {
          "id": 17943,
          "text": "<p><span style=\"font-size:12pt;\">Amount of inspired oxygen</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is measured by the device shown in the given image?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1_WaIgI6p.jpg\" alt=\"\" width=\"250\" height=\"259\"></span></p>",
      "unique_key": "Q5451532",
      "question_audio": null,
      "question_video": null,
      "map_id": 15764045,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Oxygen saturation</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Oxygen saturation (often referred to as SpO2) is the percentage of oxygen-saturated hemoglobin relative to the total hemoglobin (unsaturated + saturated) in the blood.</span></li><li><span style=\"font-size:12pt;\">The device measures this by non-invasively detecting the color change in blood as it binds oxygen.</span></li><li><span style=\"font-size:12pt;\">The image displays a reading of \"98%\", which is consistent with an SpO2 reading. Thus, this option is correct.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Oxygen content of the blood:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This refers to the amount of oxygen bound to hemoglobin in the blood plus any oxygen dissolved directly in the blood.</span></li><li><span style=\"font-size:12pt;\">Pulse oximeters do not measure the total oxygen content of the blood. They only measure the percentage of oxygen-saturated hemoglobin.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Partial pressure of oxygen:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Partial pressure of oxygen (often referred to as PaO2) is the pressure exerted by oxygen in the blood. It's typically measured using an arterial blood gas analysis.</span></li><li><span style=\"font-size:12pt;\">Pulse oximeters do not measure PaO2.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Amount of inspired oxygen:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This refers to the concentration of oxygen that a person is inhaling, often given as a percentage or fraction (FiO2).</span></li><li><span style=\"font-size:12pt;\">Pulse oximeters do not measure the amount of inspired oxygen.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Pulse oximetry measures the oxygen saturation (SpO2) of hemoglobin in the blood using the principles of Beer Lambert’s law and plethysmography.</span></p>",
      "correct_choice_id": 17940,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6449,
      "choices": [
        {
          "id": 25765,
          "text": "<p><span style=\"font-size:12.0pt;\">It acts as an P2 Y12 agonist</span></p>"
        },
        {
          "id": 25766,
          "text": "<p><span style=\"font-size:12.0pt;\">It is 10 times less potent than clopidogrel</span></p>"
        },
        {
          "id": 25767,
          "text": "<p><span style=\"font-size:12.0pt;\">It is a pro-drug</span></p>"
        },
        {
          "id": 25768,
          "text": "<p><span style=\"font-size:12.0pt;\">Omeprazole interferes with metabolism of prasugrel leading to increased risk of bleeding</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is true about prasugrel?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2018)</span></p>",
      "unique_key": "Q9500420",
      "question_audio": null,
      "question_video": null,
      "map_id": 15708917,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) It is a pro-drug</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Prasugrel is a prodrug that is metabolized by the liver to its active metabolite, which is an inhibitor of P2Y12 ADP platelet receptors. This active metabolite irreversibly inhibits platelet aggregation, making prasugrel a potent antiplatelet agent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.</strong></span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>It acts as an P2 Y12 agonist: It acts as an P2 Y12 agonist</strong> is incorrect because prasugrel is not a P2Y12 agonist but rather an inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong></span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>It is 10 times less potent than clopidogrel: </strong>It is 10 times less potent than clopidogrel is incorrect because prasugrel is actually more potent than clopidogrel.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Omeprazole interferes with metabolism of prasugrel leading to increased risk of bleeding: </strong>Omeprazole interferes with metabolism of prasugrel leading to increased risk of bleeding is incorrect because omeprazole can interfere with the activation of prasugrel to its active metabolite, reducing its antiplatelet effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Prasugrel is a pro-drug that, upon hepatic metabolism, becomes an active metabolite that irreversibly inhibits the P2Y12 ADP platelet receptors, thus preventing platelet aggregation and making it a potent antiplatelet agent.</span></p>",
      "correct_choice_id": 25767,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 573,
      "choices": [
        {
          "id": 2288,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">5 L/min</span></p>"
        },
        {
          "id": 2289,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">15 L/min</span></p>"
        },
        {
          "id": 2290,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">10 L/min</span></p>"
        },
        {
          "id": 2291,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">20 L/min</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The maximum oxygen flow rate which can be kept with a conventional Hudson oxygen mask is?</span></p>",
      "unique_key": "Q4102126",
      "question_audio": null,
      "question_video": null,
      "map_id": 15764011,
      "difficulty_level": "intermediate",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. 10 L/min</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The maximum oxygen flow rate which can be kept with a conventional oxygen mask (Simple Face Mask, also known as Hudson mask) is 10 L/min. This is a standard setting for delivering oxygen to patients who require moderate levels of oxygen supplementation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;A. 5 L/min:</strong> While 5 L/min can be used, it is not the maximum flow rate for a Hudson mask.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;B. 15 L/min</strong>: This flow rate is generally used with a non-rebreather mask rather than a conventional Hudson mask.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;D. 20 L/min:</strong> This flow rate exceeds the capacity of most conventional oxygen delivery systems like the Hudson mask.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective :</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The maximum flow rate for a conventional Hudson oxygen mask is 10 L/min.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/06/screenshot-2024-07-06-134044.jpg\" alt=\"\" width=\"700\" height=\"196\"></span></p>",
      "correct_choice_id": 2290,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 65741,
      "choices": [
        {
          "id": 262129,
          "text": "<p><span style=\"font-size:12.0pt;\">Atorvastatin</span></p>"
        },
        {
          "id": 262130,
          "text": "<p><span style=\"font-size:12.0pt;\">Fenofibrate</span></p>"
        },
        {
          "id": 262131,
          "text": "<p><span style=\"font-size:12.0pt;\">Nicotinamide</span></p>"
        },
        {
          "id": 262132,
          "text": "<p><span style=\"font-size:12.0pt;\">Ezetimibe</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient being treated for hyperlipidemia developed myopathy, mild hyperglycemia, and raised liver enzymes. Which drug is the most likely cause? <i>(Twisted PYQ)</i></span></p>",
      "unique_key": "Q9616671",
      "question_audio": null,
      "question_video": null,
      "map_id": 15755821,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. &nbsp;A) Atorvastatin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Atorvastatin, a statin, is a lipid-lowering agent used in the management of hyperlipidemia. Statins are commonly associated with side effects such as myopathy (muscle pain, weakness, or elevated creatine kinase), mild hyperglycemia, and hepatotoxicity (manifested as raised liver enzymes). These side effects are particularly important to monitor in patients on statin therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Fenofibrate:</strong> Incorrect because, while it may cause elevated liver enzymes and rarely myopathy (especially when combined with statins), it is not as strongly associated with hyperglycemia or myopathy as statins are.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Nicotinamide:</strong> Incorrect because although nicotinamide (niacin) is associated with hyperglycemia and raised liver enzymes, its hallmark side effects include flushing and gout, not myopathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Ezetimibe:</strong> Incorrect because it is generally well tolerated and is not associated with myopathy, hyperglycemia, or hepatotoxicity to the extent seen with statins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Atorvastatin, like other statins, is commonly associated with myopathy, mild hyperglycemia, and hepatotoxicity, making it the most likely cause in this clinical scenario. Monitoring liver enzymes and muscle symptoms is crucial during statin therapy.</span></p>",
      "correct_choice_id": 262129,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 65742,
      "choices": [
        {
          "id": 262133,
          "text": "<p><span style=\"font-size:12.0pt;\">Vasopressin</span></p>"
        },
        {
          "id": 262134,
          "text": "<p><span style=\"font-size:12.0pt;\">Atropine</span></p>"
        },
        {
          "id": 262135,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        },
        {
          "id": 262136,
          "text": "<p><span style=\"font-size:12.0pt;\">Magnesium sulfate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What alternative drug would you use for cardiac arrest due to asystole or pulseless electrical activity (PEA) if epinephrine is not effective? <i>(Twisted PYQ)</i></span></p>",
      "unique_key": "Q2207385",
      "question_audio": null,
      "question_video": null,
      "map_id": 15755822,
      "difficulty_level": "intermediate",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Answer: A) Vasopressin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Vasopressin is a synthetic peptide that acts on V1 receptors, causing potent vasoconstriction. While it is no longer a first-line recommendation in the most recent American Heart Association (AHA) guidelines, it can be considered as an alternative to epinephrine in specific scenarios, such as asystole or PEA, where vasopressor effects are required. Vasopressin has the advantage of longer-lasting effects compared to epinephrine and does not increase myocardial oxygen demand.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Atropine:</strong> Incorrect because atropine is not recommended in the most recent AHA guidelines for routine use in asystole or PEA. It was previously used for asystole but has been shown to have minimal benefit.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Amiodarone:</strong> Incorrect because amiodarone is used for refractory ventricular fibrillation or pulseless ventricular tachycardia, not for asystole or PEA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Magnesium sulfate:</strong> Incorrect as it is specifically used for torsades de pointes and hypomagnesemia-induced arrhythmias, not asystole or PEA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Vasopressin can serve as an alternative vasopressor in cardiac arrest scenarios like asystole or PEA when epinephrine is ineffective, though it is no longer the primary recommendation in recent guidelines. Proper assessment of the underlying cause is crucial for targeted treatment.</span></p>",
      "correct_choice_id": 262133,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44829,
      "choices": [
        {
          "id": 178963,
          "text": "<p><span style=\"font-size:12pt;\">Evolocumab</span></p>"
        },
        {
          "id": 178964,
          "text": "<p><span style=\"font-size:12pt;\">Ezetimibe</span></p>"
        },
        {
          "id": 178965,
          "text": "<p><span style=\"font-size:12pt;\">Evinacumab</span></p>"
        },
        {
          "id": 178966,
          "text": "<p><span style=\"font-size:12pt;\">Everolimus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following is a PCSK-9 inhibtior? (</span>INICET May 2024)</p>",
      "unique_key": "Q4341520",
      "question_audio": null,
      "question_video": null,
      "map_id": 15708922,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Evolocumab</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Evolocumab is a monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK-9). By inhibiting PCSK-9, evolocumab increases the number of low-density lipoprotein (LDL) receptors available on the surface of liver cells, thereby reducing LDL cholesterol levels in the blood. It is used for the treatment of hypercholesterolemia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong>&nbsp;<strong>B.</strong>&nbsp;<strong>Ezetimibe</strong>:&nbsp;Ezetimibe is a cholesterol absorption inhibitor that works by reducing the absorption of cholesterol in the small intestine. It is used to lower LDL cholesterol levels but is not a PCSK-9 inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong>&nbsp;<strong>C.</strong>&nbsp;<strong>Evinacumab</strong>:&nbsp;Evinacumab is a monoclonal antibody that inhibits angiopoietin-like protein 3 (ANGPTL3), which reduces levels of triglycerides, LDL cholesterol, and other lipids. It is used for treating homozygous familial hypercholesterolemia but is not a PCSK-9 inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Everolimus</strong>:&nbsp;Everolimus is an mTOR inhibitor used primarily as an immunosuppressant in transplant patients and in certain types of cancer. It is not related to cholesterol metabolism and is not a PCSK-9 inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In summary, evolocumab is the correct answer as it is a PCSK-9 inhibitor used to lower LDL cholesterol levels.</span></p>",
      "correct_choice_id": 178963,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57296,
      "choices": [
        {
          "id": 228561,
          "text": "<p><span style=\"font-size:12.0pt;\">BAL (British Anti-Lewisite)</span></p>"
        },
        {
          "id": 228562,
          "text": "<p><span style=\"font-size:12.0pt;\">EDTA</span></p>"
        },
        {
          "id": 228563,
          "text": "<p><span style=\"font-size:12.0pt;\">DTPA</span></p>"
        },
        {
          "id": 228564,
          "text": "<p><span style=\"font-size:12.0pt;\">Desferrioxamine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following chelating agents is contraindicated in iron poisoning? (NEET PG 2024)</span></p>",
      "unique_key": "Q3151992",
      "question_audio": null,
      "question_video": null,
      "map_id": 15708924,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) BAL (British Anti-Lewisite)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">BAL (British Anti-Lewisite), also known as dimercaprol, is contraindicated in cases of iron poisoning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">BAL should not be used in this case because it can form toxic complexes with iron, exacerbating the condition rather than alleviating it.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. EDTA:</strong> EDTA is a chelating agent used primarily for lead and other heavy metals, but it is not contraindicated in iron poisoning. However, it is not the preferred chelating agent for iron poisoning either.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. DTPA:</strong> DTPA (Diethylenetriamine pentaacetic acid) is another chelating agent used for certain radioactive heavy metals and is not specifically contraindicated in iron poisoning, although it is not used for iron either.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Desferrioxamine:</strong> Desferrioxamine is the chelating agent of choice in iron poisoning. It binds to free iron and forms a complex that is excreted in the urine, making it effective in reducing iron levels in cases of acute iron toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">BAL (British Anti-Lewisite) is contraindicated in Cadmium and Iron poisoning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Desferrioxamine is the appropriate chelating agent to use in cases of iron poisoning.</span></p>",
      "correct_choice_id": 228561,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1030,
      "choices": [
        {
          "id": 4116,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Increase flow rate to 15 L/min</span></p>"
        },
        {
          "id": 4117,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">High-flow nasal cannula oxygen therapy</span></p>"
        },
        {
          "id": 4118,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Endotracheal intubation</span></p>"
        },
        {
          "id": 4119,
          "text": "<p><span style=\"font-size:12pt;\">No specific intervention necessary</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old man who was under home isolation after testing positive for COVID-19, develops breathing difficulty and is brought to the ER. The patient is alert and responsive, but his respiratory rate is 26/min. Room air Sp02 is 86%. He is administered oxygen through a non -rebreathing mask with a flow rate of 10 L/ min. After a trial of one hour, his SpO<sub>2</sub> is 88%. What is the next step in management?</span></p>",
      "unique_key": "Q8174750",
      "question_audio": null,
      "question_video": null,
      "map_id": 15764016,
      "difficulty_level": "intermediate",
      "subjects_id": [
        19
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) High-flow nasal cannula oxygen therapy</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Mechanism of Action:</strong> HFNC can deliver warmed, humidified oxygen at high flow rates (up to 60 L/min or more), creating a positive end-expiratory pressure (PEEP) effect, reducing nasopharyngeal dead space, and improving oxygenation.</span></li><li><span style=\"font-size:12pt;\"><strong>Effectiveness:</strong> Studies have shown its effectiveness in treating acute hypoxemic respiratory failure in COVID-19 patients. Given that the patient's SpO2 didn't improve significantly with an NRB, transitioning to HFNC might be a logical step before considering more invasive measures like intubation.</span></li></ul><p>&nbsp;</p><p><span style=\"color:#434343;font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Increase flow rate to 15 L/min: </strong>The non-rebreather mask (NRB) is designed to deliver high concentrations of oxygen (up to 90%). Increasing the flow rate may slightly improve the fraction of delivered oxygen, but it may not result in significant improvement in oxygenation, especially if the cause of hypoxia isn't just a low FiO2. Therefore, merely increasing the flow rate may not be sufficient to address the patient's respiratory distress.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Endotracheal intubation: </strong>Endotracheal intubation and mechanical ventilation are invasive interventions, reserved for patients who are in respiratory failure and cannot maintain adequate oxygenation and/or ventilation with less invasive means. While this patient is hypoxic, jumping straight to intubation without trialing intermediate steps like HFNC might be premature, especially since the patient is alert and responsive.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. No specific intervention necessary: </strong>Given the patient's low SpO2 and increased respiratory rate, no intervention is not an appropriate choice. The patient is in respiratory distress and requires further measures to improve his oxygenation.</span></p><p>&nbsp;</p><p><span style=\"color:#434343;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">In a patient with COVID-19 and hypoxemia unresponsive to a non-rebreather mask, transitioning to high-flow nasal cannula oxygen therapy (HFNC) is a logical next step. HFNC can provide better oxygenation and is a less invasive option before considering endotracheal intubation.</span></li></ul>",
      "correct_choice_id": 4117,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4505,
      "choices": [
        {
          "id": 17996,
          "text": "<p><span style=\"color:black;font-size:12pt;\">IV adenosine</span></p>"
        },
        {
          "id": 17997,
          "text": "<p><span style=\"font-size:12pt;\">IV diltiazem</span></p>"
        },
        {
          "id": 17998,
          "text": "<p><span style=\"font-size:12pt;\">DC cardioversion</span></p>"
        },
        {
          "id": 17999,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Ibutilide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A 50-year-old patient with a history of hypertension and diabetes mellitus developed the following rhythm. His blood pressure was 70/40 mm Hg and he had a feeble pulse.&nbsp;What is the next step of management? (NEET PG 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1_6DETd4g.jpg\" alt=\"\" width=\"300\" height=\"120\"></span></p>",
      "unique_key": "Q7998684",
      "question_audio": null,
      "question_video": null,
      "map_id": 15763955,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) DC cardioversion</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The ECG shows supraventricular tachycardia (SVT).</span></li><li><span style=\"font-size:12pt;\">The patient is also hemodynamically unstable, as indicated by the low blood pressure (70/40 mm Hg) and feeble pulse.</span></li><li><span style=\"font-size:12pt;\">When a patient presents with SVT and hemodynamic instability, immediate rhythm conversion is essential.</span></li><li><span style=\"font-size:12pt;\">The recommended treatment in such cases is direct current (DC) cardioversion.</span></li><li><span style=\"font-size:12pt;\">This involves delivering an electric shock to the heart to restore a normal rhythm and stabilize the patient's hemodynamic status.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. IV adenosine:&nbsp;</strong>Adenosine temporarily slows or stops the heart's electrical activity and is often the first-line treatment for terminating stable, narrow complex supraventricular tachycardias (SVT). However, in hemodynamically unstable patients, its short-lived effects make it less suitable.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. IV diltiazem:&nbsp;</strong>Diltiazem is a calcium channel blocker used to control the rate in atrial fibrillation or flutter and certain types of SVT. In hemodynamically unstable patients, slowing the heart rate without converting the rhythm can be dangerous.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Ibutilide:&nbsp;</strong>Ibutilide is an antiarrhythmic drug used to treat certain types of atrial fibrillation or flutter. It's not the first-line treatment for hemodynamically unstable SVT and carries a risk of proarrhythmia, meaning it can sometimes cause new or worsening rhythm problems.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For patients with supraventricular tachycardia (SVT) and hemodynamic instability, direct current (DC) cardioversion is the recommended and most effective treatment.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Ref: Miller’s Anesthesia, 9<sup>th</sup> Ed. Pg</strong></span><span style=\"font-size:12pt;\"> <strong>1744</strong></span></p>",
      "correct_choice_id": 17998,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1075,
      "choices": [
        {
          "id": 4296,
          "text": "<p><span style=\"color:black;font-size:12pt;\">1, 2, 3 and 4</span></p>"
        },
        {
          "id": 4297,
          "text": "<p><span style=\"color:black;font-size:12pt;\">1, 2 and 4</span></p>"
        },
        {
          "id": 4298,
          "text": "<p><span style=\"color:black;font-size:12pt;\">2, 3 and 4</span></p>"
        },
        {
          "id": 4299,
          "text": "<p><span style=\"color:black;font-size:12pt;\">1 and 2 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of these is the definition of effective CPR?</span></p><p>&nbsp;</p><ol><li><span style=\"color:black;font-size:12pt;\">Respiratory rate: 20 - 24 breaths per minute.</span></li><li><span style=\"color:black;font-size:12pt;\">Chest compressions: 100-120/min.</span></li><li><span style=\"color:black;font-size:12pt;\">Allow complete chest recoil.</span></li><li><span style=\"color:black;font-size:12pt;\">5-6 cm depression.</span></li></ol>",
      "unique_key": "Q5863661",
      "question_audio": null,
      "question_video": null,
      "map_id": 15763950,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. 2, 3 and 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Components of High-Quality CPR:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/untitled-14.jpg\" alt=\"\" width=\"500\" height=\"496\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Effective CPR includes the following components:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Chest compressions: 100-120/min. This ensures that the heart is pumping enough blood to maintain circulation during cardiac arrest.</span></li><li><span style=\"font-size:12pt;\">Allow complete chest recoil. Allowing the chest to fully recoil between compressions ensures that the heart fills adequately with blood between each compression, which is crucial for effective circulation.</span></li><li><span style=\"font-size:12pt;\">5-6 cm depression. The depth of chest compressions should be between 5-6 cm (2-2.4 inches) for adults. This depth is essential to create enough pressure to maintain circulation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Respiratory rate: 20-24 breaths per minute. This is not correct for effective CPR. The recommended respiratory rate during CPR is about 10-12 breaths per minute when an advanced airway is in place. Higher respiratory rates can lead to hyperventilation, which can be detrimental.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective :</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Effective CPR is characterized by chest compressions at a rate of 100-120 per minute, allowing complete chest recoil, and compressing the chest to a depth of 5-6 cm.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Ref: Miller’s Anesthesia, 9<sup>th</sup> Ed. Pg</strong></span><span style=\"font-size:12.0pt;\"> <strong>2529-2534</strong></span></p>",
      "correct_choice_id": 4298,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4508,
      "choices": [
        {
          "id": 18008,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Physostigmine</span></p>"
        },
        {
          "id": 18009,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Neostigmine</span></p>"
        },
        {
          "id": 18010,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Carbachol</span></p>"
        },
        {
          "id": 18011,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Succinylcholine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient is given a nicotinic receptor antagonist as a muscle relaxant. Which drug is given postoperatively to recover from muscle weakness? (NEET PG 2020)</span></p>",
      "unique_key": "Q4269626",
      "question_audio": null,
      "question_video": null,
      "map_id": 15763969,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Neostigmine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For reversal of neuromuscular blockade from non-depolarizing muscle relaxants, the reversal agent of choice is Neostigmine.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Neostigmine is a cholinesterase inhibitor that boosts the concentration of acetylcholine in the neuromuscular junction, thus enhancing muscle contraction.</span></li><li><span style=\"font-size:12.0pt;\">Neostigmine is the drug of choice for reversing the effects of non-depolarizing muscle relaxants postoperatively. By preventing the breakdown of acetylcholine, it counteracts the muscle-relaxing effects of these drugs.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Physostigmine:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Physostigmine is a reversible cholinesterase inhibitor. It increases the concentration of acetylcholine at nerve endings.</span></li><li><span style=\"font-size:12.0pt;\">Physostigmine is primarily used to treat anticholinergic (atropine-like) drug overdoses. It can cross the blood-brain barrier and is used for central anticholinergic syndromes. It is not typically used for reversing neuromuscular blockade from muscle relaxants.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Carbachol:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Carbachol is a cholinergic drug that acts as an agonist at both muscarinic and nicotinic receptors.</span></li><li><span style=\"font-size:12.0pt;\">Carbachol is primarily used in ophthalmology to induce miosis or to reduce intraocular pressure. It is not used for reversing neuromuscular blockade.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Succinylcholine:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Succinylcholine is a depolarizing neuromuscular blocker. It binds to nicotinic receptors and causes prolonged depolarization, which initially causes muscle fasciculation followed by paralysis.</span></li><li><span style=\"font-size:12.0pt;\">Succinylcholine itself causes muscle paralysis and is used to facilitate intubation during anesthesia induction. It would not be used to reverse muscle relaxation; in fact, it would exacerbate it.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Neostigmine is the preferred agent for reversing the effects of non-depolarizing muscle relaxants postoperatively.</span></p>",
      "correct_choice_id": 18009,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1003,
      "choices": [
        {
          "id": 4008,
          "text": "<p><span style=\"font-size:12pt;\">Reducing the secretions</span></p>"
        },
        {
          "id": 4009,
          "text": "<p><span style=\"font-size:12pt;\">Sedative effect</span></p>"
        },
        {
          "id": 4010,
          "text": "<p><span style=\"font-size:12pt;\">Skeletal muscle relaxant</span></p>"
        },
        {
          "id": 4011,
          "text": "<p><span style=\"font-size:12pt;\">Anxiolytic</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Glycopyrrolate is used as a preanesthetic agent for?</span></p>",
      "unique_key": "Q7496084",
      "question_audio": null,
      "question_video": null,
      "map_id": 15763953,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Reducing the secretions</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Mechanism of Action:</strong> Glycopyrrolate is an anticholinergic agent, which means it acts by blocking the action of acetylcholine on muscarinic receptors.</span></li><li><span style=\"font-size:12pt;\"><strong>Effect:</strong> One of the effects of this action is the reduction in the production of secretions, such as saliva and bronchial mucus.</span></li><li><span style=\"font-size:12pt;\"><strong>Clinical Use:</strong> Given before anesthesia, it can prevent excessive secretions that might interfere with the procedure or increase the risk of aspiration. Hence, this is the primary reason glycopyrrolate is used as a preanesthetic agent.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Sedative effect: </strong>Glycopyrrolate does not have inherent sedative properties. While it may have some central side effects due to its anticholinergic action, its quaternary structure limits its ability to cross the blood-brain barrier. Thus, it doesn't produce sedation in the same manner as agents specifically designed for that purpose, like benzodiazepines.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Skeletal muscle relaxant: </strong>Glycopyrrolate does not have skeletal muscle relaxant properties.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Anxiolytic: </strong>Glycopyrrolate is not used as an anxiolytic.</span></p><p>&nbsp;</p><h3><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></h3><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Glycopyrrolate is primarily used as a preanesthetic agent to reduce secretions, thus preventing complications during anesthesia and surgery.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Miller’s Anesthesia, 9<sup>th</sup> Ed. Pg 849</strong></span></p>",
      "correct_choice_id": 4008,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1026,
      "choices": [
        {
          "id": 4100,
          "text": "<p><span style=\"font-size:12pt;\">Mechanical ventilator</span></p>"
        },
        {
          "id": 4101,
          "text": "<p><span style=\"font-size:12pt;\">Infusion pump</span></p>"
        },
        {
          "id": 4102,
          "text": "<p><span style=\"font-size:12pt;\">CPAP machine</span></p>"
        },
        {
          "id": 4103,
          "text": "<p><span style=\"font-size:12.0pt;\">High flow nasal cannula</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Identify the equipment shown in the image below?</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/26/untitled-111.jpg\" alt=\"\" width=\"300\" height=\"307\"></span></p><p>&nbsp;</p>",
      "unique_key": "Q2994468",
      "question_audio": null,
      "question_video": null,
      "map_id": 15764015,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) High flow nasal cannula</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Components:</strong></span><ul><li><span style=\"font-size:12pt;\"><strong>Flow generator:</strong> This delivers a continuous flow of medical gas, which can be up to 60 liters per minute (L/min) or more in some devices.</span></li><li><span style=\"font-size:12pt;\"><strong>Heated humidifier:</strong> The gas is passed through a humidifier, which warms and saturates the gas with water vapor, providing near 100% humidity. This prevents mucosal drying and enhances mucociliary clearance.</span></li><li><span style=\"font-size:12pt;\"><strong>Nasal cannula:</strong> Despite the term \"nasal cannula,\" the prongs for HFNC are broader and shorter than traditional cannulas. They don't completely occlude the nares, allowing for the patient to breathe room air in addition to the provided gas mixture if needed.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Mechanism of Action:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Gas Conditioning:</strong> The humidified and warmed gas ensures better comfort and reduced airway resistance, potentially improving mucociliary function.</span></li><li><span style=\"font-size:12pt;\"><strong>PEEP Effect:</strong> The high flow rates create a degree of positive end-expiratory pressure (PEEP) in the nasopharynx. This can be beneficial in preventing alveolar collapse and can recruit alveoli, improving oxygenation.</span></li><li><span style=\"font-size:12pt;\"><strong>Enhanced CO2 Washout:</strong> HFNC reduces the anatomical dead space in the nasopharynx, aiding in more efficient removal of carbon dioxide.</span></li><li><span style=\"font-size:12pt;\"><strong>Continuous High Flow:</strong> The high flow rates ensure that the fraction of inspired oxygen (FiO2) is more consistent, irrespective of the patient's respiratory pattern.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Advantages:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Better oxygenation:</strong> By delivering higher flow rates, HFNC can achieve better and more consistent oxygenation compared to standard oxygen therapy.</span></li><li><span style=\"font-size:12pt;\"><strong>Comfort:</strong> Patients often find HFNC more comfortable than non-invasive positive pressure ventilation masks.</span></li><li><span style=\"font-size:12pt;\"><strong>Flexibility:</strong> Patients can eat, drink, and communicate while using HFNC.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Indications:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Acute hypoxemic respiratory failure:</strong> Especially if caused by conditions like pneumonia or pulmonary edema.</span></li><li><span style=\"font-size:12pt;\"><strong>Post-extubation support:</strong> In patients at risk for reintubation.</span></li><li><span style=\"font-size:12pt;\"><strong>During procedures:</strong> Like bronchoscopy, to maintain oxygenation.</span></li><li><span style=\"font-size:12pt;\"><strong>In conditions like COPD and asthma:</strong> It may aid in CO2 washout.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Limitations and Contraindications:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Severe hypercapnic respiratory failure:</strong> HFNC doesn't provide as much ventilation support as bilevel positive airway pressure (BiPAP) or mechanical ventilation.</span></li><li><span style=\"font-size:12pt;\"><strong>Uncooperative or unconscious patients:</strong> Due to aspiration risk.</span></li><li><span style=\"font-size:12pt;\"><strong>Facial trauma or recent facial surgery.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"color:#434343;font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Mechanical ventilator:&nbsp;</strong>A mechanical ventilator is a device used to support or replace spontaneous breathing. It is more complex and provides controlled ventilation through an endotracheal tube or tracheostomy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Infusion pump:&nbsp;</strong>An infusion pump delivers fluids, such as nutrients and medications, into a patient's body in controlled amounts. It is not related to respiratory support.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. CPAP machine:&nbsp;</strong>A Continuous Positive Airway Pressure (CPAP) machine delivers a continuous level of positive airway pressure to keep the airways open. It is commonly used in sleep apnea but does not provide the high flow rates and humidification characteristic of HFNC.</span></p><p>&nbsp;</p><p><span style=\"color:#434343;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">High flow nasal cannula (HFNC) is a respiratory support system that delivers high flow rates of humidified and warmed oxygen, providing benefits such as improved oxygenation, patient comfort, and flexibility in use.</span></li></ul>",
      "correct_choice_id": 4103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ImageBased",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43257,
      "choices": [
        {
          "id": 172695,
          "text": "<p><span style=\"font-size:12pt;\">Mild illness</span></p>"
        },
        {
          "id": 172696,
          "text": "<p><span style=\"font-size:12pt;\">&nbsp;Moderate illness</span></p>"
        },
        {
          "id": 172697,
          "text": "<p><span style=\"font-size:12pt;\">&nbsp;Severe illness which is&nbsp; constant threat to life</span></p>"
        },
        {
          "id": 172698,
          "text": "<p><span style=\"font-size:12.0pt;\">Severe illness</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following criteria corresponding to ASA grade III?&nbsp;</span>(INICET NOVEMBER 2023)</p>",
      "unique_key": "Q3781122",
      "question_audio": null,
      "question_video": null,
      "map_id": 15763960,
      "difficulty_level": "intermediate",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D.&nbsp;Severe illness</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><strong>Option&nbsp;</strong><span style=\"font-size:12pt;\"><strong>D. Severe illness:</strong> The American Society of Anesthesiologists (ASA) Physical Status Classification System is used to assess and communicate a patient's pre-anesthesia medical co-morbidities. ASA grade III is defined as a patient with severe systemic disease that is not incapacitating. This means the patient has a serious illness, but it does not necessarily pose a constant threat to life, which would correspond to ASA IV.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">&nbsp;<strong>Option&nbsp;A. Mild illness</strong>: This corresponds to ASA II, which is defined as a patient with mild systemic disease. It does not reach the severity required for ASA III.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;B. Moderate illness</strong>: This is not an official ASA classification term. The closest would be ASA II (mild systemic disease) or ASA III (severe systemic disease).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;C. Severe illness which is a constant threat to life: </strong>This corresponds to ASA IV. It describes a patient with severe systemic disease that poses a constant threat to life, not ASA III.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">ASA grade III corresponds to a patient with severe systemic disease that is not incapacitating.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>The classification system is as follows:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\"><strong>ASA I</strong>: A normal healthy patient.</span></li><li><span style=\"font-size:12pt;\"><strong>ASA II</strong>: A patient with mild systemic disease.</span></li><li><span style=\"font-size:12pt;\"><strong>ASA III</strong>: A patient with severe systemic disease that is not incapacitating.</span></li><li><span style=\"font-size:12pt;\"><strong>ASA IV</strong>: A patient with severe systemic disease that is a constant threat to life.</span></li><li><span style=\"font-size:12pt;\"><strong>ASA V</strong>: A moribund patient who is not expected to survive without the operation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>ASA VI</strong>: A declared brain-dead patient whose organs are being removed for donor purposes.</span></li></ol>",
      "correct_choice_id": 172698,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1029,
      "choices": [
        {
          "id": 4112,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">6 weeks</span></p>"
        },
        {
          "id": 4113,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">8-10 weeks</span></p>"
        },
        {
          "id": 4114,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">12 weeks</span></p>"
        },
        {
          "id": 4115,
          "text": "<p><span style=\"font-size:12pt;\">4 weeks</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">How long should elective surgery be deferred for a patient who had cough and fever, after he has recovered from COVID-19, and has not required any hospitalization?</span></p>",
      "unique_key": "Q7762113",
      "question_audio": null,
      "question_video": null,
      "map_id": 15763962,
      "difficulty_level": "intermediate",
      "subjects_id": [
        19
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) 6 weeks</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Elective surgery deferral based on respiratory disease severity and COVID-19 recovery:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>4 weeks:</strong> For an asymptomatic patient with mild respiratory symptoms.</span></li><li><span style=\"font-size:12pt;\"><strong>6 weeks:</strong> For a symptomatic patient who did not need hospital treatment.</span></li><li><span style=\"font-size:12pt;\"><strong>8 weeks:</strong> For a symptomatic patient who was hospitalized in the ward.</span></li><li><span style=\"font-size:12pt;\"><strong>12 weeks:</strong> For a patient who was admitted to the intensive care unit due to respiratory infection.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Application:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">As this patient was symptomatic but did not need hospitalization, elective surgery can be deferred for 6 weeks.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. 8-10 weeks: </strong>This timeline is recommended for symptomatic patients who were hospitalized in the ward, which does not apply to this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. 12 weeks: </strong>This timeline is for patients who were admitted to the intensive care unit due to a respiratory infection, which also does not apply to this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. 4 weeks: </strong>This timeline is for asymptomatic patients with mild respiratory symptoms, which is not the case for this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Elective surgery should be deferred for 6 weeks in a patient who had cough and fever due to COVID-19 but did not require hospitalization. This ensures sufficient recovery time to reduce perioperative risks.</span></li></ul><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ref: Miller’s Anesthesia, 9<sup>th</sup> Ed. Pg</strong> <strong>2423</strong></span></p>",
      "correct_choice_id": 4112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57488,
      "choices": [
        {
          "id": 229325,
          "text": "<p><span style=\"font-size:12.0pt;\">Sugammadex</span></p>"
        },
        {
          "id": 229326,
          "text": "<p><span style=\"font-size:12.0pt;\">Physostigmine</span></p>"
        },
        {
          "id": 229327,
          "text": "<p><span style=\"font-size:12.0pt;\">Rivastigmine</span></p>"
        },
        {
          "id": 229328,
          "text": "<p><span style=\"font-size:12.0pt;\">Succinylcholine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of these is used for immediate reversal of Vecuronium in a patient for normal kidney function? (NEET PG 2024)</span></p>",
      "unique_key": "Q1288588",
      "question_audio": null,
      "question_video": null,
      "map_id": 15764012,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Sugammadex</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sugammadex is a selective relaxant binding agent / cyclodextrin molecule used to reverse the effects of certain non-depolarizing neuromuscular blocking agents, particularly rocuronium and vecuronium. It works by encapsulating the vecuronium molecule, thereby rendering it inactive and allowing for rapid reversal of muscle paralysis. Sugammadex is particularly advantageous in cases where quick recovery from neuromuscular blockade is required, and it is effective in patients with normal kidney function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Physostigmine:</strong> Physostigmine is a cholinesterase inhibitor used primarily to reverse the effects of anticholinergic toxicity. It is not used to reverse neuromuscular blockade caused by vecuronium.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Rivastigmine:</strong> Rivastigmine is a cholinesterase inhibitor used in the treatment of Alzheimer's disease and other forms of dementia. It has no role in reversing neuromuscular blockade.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Succinylcholine:</strong> Succinylcholine is a depolarizing muscle relaxant used to induce short-term paralysis, typically for intubation. It is not used to reverse the effects of non-depolarizing neuromuscular blockers like vecuronium; rather, it is itself a paralytic agent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sugammadex is the drug of choice for the immediate reversal of vecuronium-induced neuromuscular blockade</span></p>",
      "correct_choice_id": 229325,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/57488/Neet_Pg_Aug_2024_Anesthesia_Q_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/57488/Neet_Pg_Aug_2024_Anesthesia_Q_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20589,
      "choices": [
        {
          "id": 82319,
          "text": "<p><span style=\"font-size:12.0pt;\">Unconsciousness with pulse and breathing absent</span></p>"
        },
        {
          "id": 82320,
          "text": "<p><span style=\"font-size:12.0pt;\">Unconsciousness with pulse present and breathing absent</span></p>"
        },
        {
          "id": 82321,
          "text": "<p><span style=\"font-size:12.0pt;\">Unconsciousness with pulse and breathing present</span></p>"
        },
        {
          "id": 82322,
          "text": "<p><span style=\"font-size:12.0pt;\">Unconsciousness with pulse absent and breathing present</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">During resuscitation, when is the given position? (</span>NEET PG 2023)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/05/whatsapp-image-2023-06-12-at-190121011026.jpg\" alt=\"\" width=\"400\" height=\"154\"></span></p>",
      "unique_key": "Q4251236",
      "question_audio": null,
      "question_video": null,
      "map_id": 15763964,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Unconsciousness with pulse and breathing present</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is the recovery position, indicated in post-op patients who are awake or drowsy or unconscious with pulse and breathing present to prevent aspiration of any secretions or vomit.</span></p><p><span style=\"font-size:9pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Unconsciousness with pulse and breathing absent:</strong> Means the patient is in cardiac arrest and requires immediate resuscitation measures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Unconsciousness with pulse present and breathing</strong> <strong>absent: </strong>This is respiratory arrest and rescue breathing or bag-valve-mask ventilation should be initiated to maintain breathing of patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Unconsciousness with pulse absent and breathing present</strong>: This seems very theoretical because with a lack of circulation, breathing isn’t feasible.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The recovery position is used for an unconscious patient who has a pulse and is breathing to prevent aspiration and maintain airway patency.</span></p>",
      "correct_choice_id": 82321,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4487,
      "choices": [
        {
          "id": 17925,
          "text": "<p><span style=\"font-size:12pt;\">Ketamine</span></p>"
        },
        {
          "id": 17926,
          "text": "<p><span style=\"font-size:12pt;\">Propofol</span></p>"
        },
        {
          "id": 17927,
          "text": "<p><span style=\"font-size:12pt;\">Etomidate</span></p>"
        },
        {
          "id": 17928,
          "text": "<p><span style=\"font-size:12pt;\">Thiopentone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following elicits maximum pain on injection?&nbsp;</span>(NEET PG 2019)</p>",
      "unique_key": "Q6379896",
      "question_audio": null,
      "question_video": null,
      "map_id": 15763951,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Propofol</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Propofol is notorious for causing pain upon injection.</span></li><li><span style=\"font-size:12pt;\">The pain can be severe and is often described as a burning sensation.</span></li><li><span style=\"font-size:12pt;\">Various techniques and adjuncts, like mixing with lidocaine or injecting into larger veins, have been recommended to minimize the pain.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Ketamine: </strong>While ketamine can sometimes cause a burning sensation upon injection, it's not typically described as the most painful among anesthetic agents. However, when not combined with other medications, it can cause some discomfort upon injection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Etomidate: </strong>Etomidate can cause pain on injection, but the pain is generally less severe compared to propofol.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Thiopentone: </strong>Thiopentone can cause some pain upon injection, but it's generally less painful than propofol. However, it can cause tissue necrosis if it is inadvertently injected outside of the vein (extravasation).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Propofol is known to cause maximum pain on injection, often described as a severe burning sensation.</span></p>",
      "correct_choice_id": 17926,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 29279,
      "choices": [
        {
          "id": 117022,
          "text": "<p><span style=\"font-size:12.0pt;\">Prednisolone</span></p>"
        },
        {
          "id": 117023,
          "text": "<p><span style=\"font-size:12.0pt;\">Prazosin</span></p>"
        },
        {
          "id": 117024,
          "text": "<p><span style=\"font-size:12.0pt;\">Adrenaline</span></p>"
        },
        {
          "id": 117025,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-snake venom</span></p>"
        }
      ],
      "text": "<p style=\"margin-left:4px;text-align:justify;\"><span style=\"font-size:12.0pt;\">A young boy recently visited a temple with his grandmother. Upon returning, he has been crying inconsolably, presenting with cold extremities and a blood pressure of 170/100 mm Hg. What is the most appropriate course of treatment for his condition?&nbsp;</span>(INICET MAY 2023)</p>",
      "unique_key": "Q1887978",
      "question_audio": null,
      "question_video": null,
      "map_id": 15708909,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Prazosin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's symptoms are suggestive of scorpion sting, characterized by symptoms of vasoconstriction like hypertension and cold extremities. Prazosin, an alpha-1 blocker is drug of choice for treatment of scorpion sting.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Prednisolone</strong>: Prednisolone is a corticosteroid that reduces inflammation and suppresses the immune response. However, it is not typically used to manage scorpion stings, as it does not address the acute hypertensive crisis and autonomic storm caused by the sting.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Adrenaline</strong>: Adrenaline (epinephrine) is a catecholamine that increases heart rate and blood pressure. It would likely exacerbate the hypertension and vasoconstriction already present in the patient, making it an inappropriate treatment choice for scorpion sting.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Anti-snake venom</strong>: Anti-snake venom is used to neutralize the effects of snake bites. The symptoms described do not align with a snake bite but rather with a scorpion sting, making this treatment inappropriate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The most appropriate treatment for a scorpion sting, which presents with severe pain, hypertension, and cold extremities, is prazosin. It effectively counters the effects of excessive catecholamine release by blocking alpha-1 adrenergic receptors, thereby reducing vasoconstriction and lowering blood pressure.</span></p>",
      "correct_choice_id": 117023,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5513,
      "choices": [
        {
          "id": 22024,
          "text": "<p><span style=\"font-size:12.0pt;\">Colchicine</span></p>"
        },
        {
          "id": 22025,
          "text": "<p><span style=\"font-size:12.0pt;\">Probenecid</span></p>"
        },
        {
          "id": 22026,
          "text": "<p><span style=\"font-size:12.0pt;\">Allopurinol</span></p>"
        },
        {
          "id": 22027,
          "text": "<p><span style=\"font-size:12.0pt;\">Febuxostat</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 40-year-old male patient presents to hospital with pain in great toe. His serum uric acid was raised. He was given a medication to relieve the pain and inflammation and after that, he was put on a drug for long term treatment of gout. Which of the following drug increases the excretion of uric acid in urine? (Fmge Jan 2023)</span></p>",
      "unique_key": "Q6696995",
      "question_audio": null,
      "question_video": null,
      "map_id": 15708918,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. B. Probenecid</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Probenecid increases the excretion of uric acid in urine by inhibiting the tubular reabsorption of uric acid. It is a uricosuric drug.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Examples of other uricosuric drugs are Sulfinpyrazone, Benzbromarone and Lesinurad.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A. Colchicine:</strong> Colchicine is used primarily for the treatment of acute gout attacks. It works by inhibiting granulocyte migration and reducing inflammation, but it does not increase the excretion of uric acid.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C. Allopurinol:</strong> Allopurinol is a xanthine oxidase inhibitor that reduces the production of uric acid by inhibiting the enzyme xanthine oxidase, which is involved in the conversion of hypoxanthine to xanthine and xanthine to uric acid.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D. Febuxostat:</strong> Febuxostat is also a xanthine oxidase inhibitor, similar to allopurinol. It reduces the production of uric acid by inhibiting xanthine oxidase.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Probenecid is a uricosuric drug that increases the excretion of uric acid in the urine by inhibiting its reabsorption in the renal tubules. This makes it effective for the long-term management of gout by lowering serum uric acid levels. Other drugs like colchicine, allopurinol, and febuxostat have different mechanisms of action and do not increase uric acid excretion in the urine.</span></p>",
      "correct_choice_id": 22025,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54680,
      "choices": [
        {
          "id": 218185,
          "text": "<p><span style=\"font-size:12.0pt;\">Only a</span></p>"
        },
        {
          "id": 218186,
          "text": "<p><span style=\"font-size:12.0pt;\">Only a &amp; b</span></p>"
        },
        {
          "id": 218187,
          "text": "<p><span style=\"font-size:12.0pt;\">a, b &amp; c</span></p>"
        },
        {
          "id": 218188,
          "text": "<p><span style=\"font-size:12.0pt;\">a, c &amp; d</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of these are the components of high-quality CPR? (INICET MAY 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">a) Compression rate 100-120/min</span></p><p><span style=\"font-size:12.0pt;\">b) Depth of compression in adults is 3-4 cm</span></p><p><span style=\"font-size:12.0pt;\">c) Ventilation of 2 breaths for every 30 compressions</span></p><p><span style=\"font-size:12.0pt;\">d) Allow complete chest recoil</span></p>",
      "unique_key": "Q2173865",
      "question_audio": null,
      "question_video": null,
      "map_id": 15763954,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D) a, c &amp; d</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">High-quality CPR in adults requires several critical components to be effective. These include:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>a. Compression Rate:</strong> The compression rate should be between 100-120 compressions per minute. This rate is optimal to maintain blood flow during cardiac arrest.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>b. Depth of Compression:</strong> For adults, the correct depth of compression is at least 2 inches (approximately 5 cm). The depth mentioned in the option B (3-4 cm) is incorrect as it is insufficient to generate adequate blood flow.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>c. Ventilation:</strong> The recommended ventilation ratio is 2 breaths for every 30 compressions if no advanced airway is in place. This ensures adequate oxygenation during CPR.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>d. Chest Recoil:</strong> Allowing complete chest recoil after each compression is essential. This allows the heart to refill with blood between compressions, which is crucial for effective circulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For high-quality CPR in adults, ensure a compression rate of 100-120/min, a compression depth of at least 2 inches (5 cm), a ventilation ratio of 30:2, and allow complete chest recoil between compressions.</span></p>",
      "correct_choice_id": 218188,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 35034,
      "choices": [
        {
          "id": 139947,
          "text": "<p><span style=\"font-size:12pt;\">Tracheostomy</span></p>"
        },
        {
          "id": 139948,
          "text": "<p><span style=\"font-size:12pt;\">Orotracheal intubation</span></p>"
        },
        {
          "id": 139949,
          "text": "<p><span style=\"font-size:12pt;\">Nasotracheal intubation</span></p>"
        },
        {
          "id": 139950,
          "text": "<p><span style=\"font-size:12pt;\">Oxygen therapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">What is the airway management of choice in a patient with maxillofacial trauma after a road traffic accident?&nbsp;</span>(FMGE JANUARY 2024)</p>",
      "unique_key": "Q3619875",
      "question_audio": null,
      "question_video": null,
      "map_id": 15764039,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Tracheostomy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Tracheostomy is the preferred airway management technique in cases of severe maxillofacial trauma. This approach is chosen because severe facial injuries can make other forms of intubation difficult or impossible due to anatomical disruptions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Orotracheal Intubation:</strong> Typically the first-line method in emergency airway management, it may be contraindicated or challenging in maxillofacial trauma due to the risk of causing further injury.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Nasotracheal Intubation:</strong> Avoided in maxillofacial injuries due to the risk of creating a false passage or worsening a basal skull fracture.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Oxygen Therapy:</strong> While important for providing oxygen, it does not secure the airway and is insufficient in cases of airway compromise.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In severe maxillofacial trauma where the airway is compromised, an emergency tracheostomy is often necessary if orotracheal intubation is not feasible or safe due to the extent of the injuries.</span></p>",
      "correct_choice_id": 139947,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/35034/FMGE_Jan_-_2024_Anesthesia_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "FMGE",
        "InstrumentsBased",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/35034/FMGE_Jan_-_2024_Anesthesia_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54802,
      "choices": [
        {
          "id": 218673,
          "text": "<p><span style=\"font-size:12.0pt;\">Healthy patient</span></p>"
        },
        {
          "id": 218674,
          "text": "<p><span style=\"font-size:12.0pt;\">Mild disease</span></p>"
        },
        {
          "id": 218675,
          "text": "<p><span style=\"font-size:12.0pt;\">Moderate disease</span></p>"
        },
        {
          "id": 218676,
          "text": "<p><span style=\"font-size:12.0pt;\">Morbid patient</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following comes under ASA grade 1?</span></p>",
      "unique_key": "Q4450066",
      "question_audio": null,
      "question_video": null,
      "map_id": 15764013,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>A) Healthy patient</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The American Society of Anesthesiologists (ASA) Physical Status Classification System is a system used to assess the fitness of patients before surgery. It classifies patients into six different categories based on their overall health:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>ASA 1:</strong> A <strong>Normal, healthy patient</strong> with no systemic disease and no significant medical problems.</span></li><li><span style=\"font-size:12.0pt;\"><strong>ASA 2:&nbsp;</strong>A patient with <strong>mild systemic disease</strong> that does not limit physical activity (e.g., mild asthma or controlled hypertension).</span></li><li><span style=\"font-size:12.0pt;\"><strong>ASA 3:&nbsp;</strong>A patient with <strong>severe systemic disease</strong> that limits activity but is not incapacitating (e.g., uncontrolled diabetes or hypertension).</span></li><li><span style=\"font-size:12.0pt;\"><strong>ASA 4:&nbsp;</strong>A patient with <strong>severe systemic disease that is a</strong> <strong>constant threat to life</strong> (e.g., unstable angina, advanced COPD).</span></li><li><span style=\"font-size:12.0pt;\"><strong>ASA 5:&nbsp;</strong>A <strong>moribund patient</strong> who is <strong>not expected to survive without surgery</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(e.g., massive trauma, ruptured aneurysm).</span></li><li><span style=\"font-size:12.0pt;\"><strong>ASA 6:&nbsp;</strong>A <strong>brain-dead patient</strong> whose organs are being removed for donor purposes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this classification, <strong>ASA grade 1</strong> is designated for a healthy patient with no significant medical problems.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Mild disease:</strong> Incorrect because this describes an ASA grade 2 patient, who has a mild systemic disease that is under control and does not significantly impact their overall health.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Moderate disease:</strong> Incorrect because this describes an ASA grade 3 patient, who has a moderate to severe systemic disease that limits their activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Morbid patient:</strong> Incorrect because this describes an ASA grade 5 patient, who is moribund and at a high risk of death without surgical intervention.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">ASA grade 1 refers to a normal, healthy patient with no comorbidities or systemic diseases.</span></p>",
      "correct_choice_id": 218673,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 65728,
      "choices": [
        {
          "id": 262077,
          "text": "<p><span style=\"font-size:12.0pt;\">Pioglitazone</span></p>"
        },
        {
          "id": 262078,
          "text": "<p><span style=\"font-size:12.0pt;\">Pramlintide</span></p>"
        },
        {
          "id": 262079,
          "text": "<p><span style=\"font-size:12.0pt;\">Glimepiride</span></p>"
        },
        {
          "id": 262080,
          "text": "<p><span style=\"font-size:12.0pt;\">Metformin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 52-year-old patient with type 2 diabetes mellitus presents with unexplained nausea and bloating. The symptoms started after the initiation of a new medication. Which of the following anti-diabetic drugs is most likely associated with these symptoms? <i>(Twisted PYQ)</i></span></p>",
      "unique_key": "Q5099154",
      "question_audio": null,
      "question_video": null,
      "map_id": 15754959,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Pramlintide</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pramlintide is an amylin analog used as an adjunctive treatment in diabetes. It slows gastric emptying and promotes satiety, which can lead to nausea and bloating as common side effects. These symptoms are often dose-dependent and tend to diminish with continued use.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other</strong> <strong>Options</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pioglitazone:</strong> Incorrect as it is not associated with nausea or bloating. Its common side effects include weight gain, edema, and increased risk of heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Glimepiride:</strong> Incorrect because it primarily causes hypoglycemia rather than gastrointestinal symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D Metformin:</strong> Incorrect because although metformin causes gastrointestinal side effects, the most prominent symptom is diarrhea, not nausea and bloating specifically.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pramlintide commonly causes gastrointestinal symptoms like nausea and bloating due to its effect on gastric motility. Recognizing these side effects is crucial for appropriate management.</span></p>",
      "correct_choice_id": 262078,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44786,
      "choices": [
        {
          "id": 178791,
          "text": "<p><span style=\"font-size:12pt;\">Dapagliflozin</span></p>"
        },
        {
          "id": 178792,
          "text": "<p><span style=\"font-size:12pt;\">Pioglitazone</span></p>"
        },
        {
          "id": 178793,
          "text": "<p><span style=\"font-size:12pt;\">Sitagliptin</span></p>"
        },
        {
          "id": 178794,
          "text": "<p><span style=\"font-size:12pt;\">Metformin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following anti-diabetic drug is associated with increased risk of urinary tract infections? (</span>INICET May 2024)</p>",
      "unique_key": "Q4462466",
      "question_audio": null,
      "question_video": null,
      "map_id": 15708912,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Dapagliflozin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Dapagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor. SGLT2 inhibitors work by promoting the excretion of glucose through the urine. This increased urinary glucose can create an environment that promotes the growth of bacteria, thereby increasing the risk of urinary tract infections. This class of drugs is well known for its association with UTIs and genital infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>B.</strong>&nbsp;<strong>Pioglitazone</strong>:&nbsp;Pioglitazone is a thiazolidinedione that improves insulin sensitivity. It is not associated with an increased risk of urinary tract infections. Common side effects include weight gain, edema, and an increased risk of heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>C.</strong>&nbsp;<strong>Sitagliptin</strong>:&nbsp;Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by increasing incretin levels, which in turn increase insulin secretion and decrease glucagon secretion. Sitagliptin is not commonly associated with an increased risk of urinary tract infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Metformin</strong>:&nbsp;Metformin is a biguanide that decreases hepatic glucose production and improves insulin sensitivity. It is not associated with an increased risk of urinary tract infections. Common side effects of metformin include gastrointestinal disturbances such as diarrhea and abdominal discomfort.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, dapagliflozin, an SGLT2 inhibitor, is associated with an increased risk of urinary tract infections due to its mechanism of increasing glucose excretion in the urine. This patient’s recurrent UTIs could be related to her use of dapagliflozin.</span></p>",
      "correct_choice_id": 178791,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20456,
      "choices": [
        {
          "id": 81785,
          "text": "<p><span style=\"font-size:12pt;\">Circumference of the tube</span></p>"
        },
        {
          "id": 81786,
          "text": "<p><span style=\"font-size:12pt;\">Length of the tube</span></p>"
        },
        {
          "id": 81787,
          "text": "<p><span style=\"font-size:12pt;\">Diameter of the tube</span></p>"
        },
        {
          "id": 81788,
          "text": "<p><span style=\"font-size:12pt;\">Curvature of the tube</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Airway resistance in endotracheal tube is dependent on: (FMGE JANUARY 2023)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/25/screenshot-2024-06-25-131329.jpg\" alt=\"\" width=\"300\" height=\"132\"></p>",
      "unique_key": "Q3486889",
      "question_audio": null,
      "question_video": null,
      "map_id": 15763966,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Diameter of the tube</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The diameter of the endotracheal tube is the primary factor affecting airway resistance. According to Poiseuille's law, the resistance (R) to airflow through a tube is inversely proportional to the fourth power of the radius (r) of the tube (R ∝ 1/r^4). This means that even a small reduction in the diameter of the tube will result in a significant increase in resistance. The law can be expressed as R = 8ηL/πr^4, where η is the viscosity of the gas, L is the length of the tube, and r is the radius of the tube. Therefore, a larger diameter tube will have lower resistance and allow for easier airflow.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Circumference of the tube:</strong> The circumference is indirectly related to the diameter, but it does not directly influence the resistance as significantly as the diameter itself.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Length of the tube:</strong> While the length of the tube does affect resistance (longer tubes increase resistance), it is not as impactful as the diameter. The resistance is directly proportional to the length (R ∝ L).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Curvature of the tube:</strong> The curvature can affect the ease of intubation and positioning but does not significantly impact resistance in a straightforward manner compared to the diameter.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Understanding Poiseuille's law is crucial for selecting appropriate endotracheal tubes. The diameter of the tube has the most significant impact on airway resistance. A larger diameter tube will decrease resistance, facilitating easier ventilation and oxygenation of the patient.</span></p>",
      "correct_choice_id": 81787,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "ImageBased",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20455,
      "choices": [
        {
          "id": 81781,
          "text": "<p><span style=\"font-size:12pt;\">Uncuffed tracheostomy tube</span></p>"
        },
        {
          "id": 81782,
          "text": "<p><span style=\"font-size:12pt;\">Cuffed tracheostomy tube</span></p>"
        },
        {
          "id": 81783,
          "text": "<p><span style=\"font-size:12pt;\">Metallic tracheostomy tube</span></p>"
        },
        {
          "id": 81784,
          "text": "<p><span style=\"font-size:12pt;\">Endotracheal tube</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">An unconscious patient in ICU is on endotracheal intubation and now needs a tracheostomy. What type of tube should be considered in this situation? (FMGE JANUARY 2023)</span></p>",
      "unique_key": "Q7645786",
      "question_audio": null,
      "question_video": null,
      "map_id": 15763952,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Cuffed tracheostomy tube</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Cuffed tracheostomy tube</strong>: This type of tube is preferred for patients who require prolonged mechanical ventilation. The cuff can be inflated to:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Prevent Aspiration</strong>: The cuff acts as a barrier, preventing secretions from the upper airway from entering the trachea and lungs.</span></li><li><span style=\"font-size:12pt;\"><strong>Maintain Positive Pressure Ventilation</strong>: The cuff ensures that air does not leak around the tracheostomy tube, which is crucial for effective mechanical ventilation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Uncuffed tracheostomy tube</strong>: Not suitable for patients who are at risk of aspiration or who require positive pressure ventilation since it does not provide a seal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Metallic tracheostomy tube</strong>: Typically used in long-term tracheostomies but lacks a cuff, which means it cannot prevent aspiration or maintain a seal for positive pressure ventilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Endotracheal tube</strong>: This is used for short-term airway management and is not suitable for long-term tracheostomy requirements.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For unconscious patients in ICU requiring prolonged mechanical ventilation, a cuffed tracheostomy tube is the preferred choice. The cuff provides a seal to prevent aspiration and ensure effective positive pressure ventilation, making it safer and more effective for such patients.</span></p>",
      "correct_choice_id": 81782,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5511,
      "choices": [
        {
          "id": 22016,
          "text": "<p><span style=\"font-size:12.0pt;\">Repeated administration of ephedrine decreases its effect on blood pressure</span></p>"
        },
        {
          "id": 22017,
          "text": "<p><span style=\"font-size:12.0pt;\">High dose of acetylcholine after pretreatment with atropine produces increase in blood pressure and heart rate</span></p>"
        },
        {
          "id": 22018,
          "text": "<p><span style=\"font-size:12.0pt;\">A patient pre-treated with phentolamine develops severe hypotension on administration of adrenaline</span></p>"
        },
        {
          "id": 22019,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase in blood pressure is produced by intravenous propranolol</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following correctly describes the phenomenon of vasomotor reversal of Dale? (Fmge Jan 2023)</span></p>",
      "unique_key": "Q3644551",
      "question_audio": null,
      "question_video": null,
      "map_id": 15708908,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. C. A patient pre-treated with phentolamine develops severe hypotension on administration of adrenaline</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Vasomotor Reversal of Dale:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Adrenaline stimulates both α1 and β2 receptors. The α1 receptors have very strong vasoconstrictor property whereas the β2 receptors are very sensitive receptors and they cause vasodilation. Since the α1 receptors are stronger, on administration of adrenaline, they are stimulated leading to vasoconstriction. After some time, metabolism takes place and only β2 is stimulated which causes low blood pressure. This phase does not also last for a long time as metabolism happens and brings back the blood pressure to the normal level. This is the biphasic response of adrenaline (two phases in which BP increases in the first phase and decreases in the second).</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Phentolamine is a non-selective alpha blocker. So if adrenaline is administered along with it , then the alpha receptor stimulation will not happen , and there will be only stimulation of the β2 receptors leading to vasodilation and severe hypotension. This phenomenon of a patient pretreated with phentolamine developing severe hypotension on the administration of adrenaline is known as the vasomotor reversal of Dale.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/10/picture40.jpg\" alt=\"\" width=\"500\" height=\"266\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A. Repeated administration of ephedrine decreases its effect on blood pressure:</strong> This describes tachyphylaxis, which is a rapid decrease in response to a drug after repeated doses, not vasomotor reversal of Dale.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B. High dose of acetylcholine after pretreatment with atropine produces an increase in blood pressure and heart rate:</strong> This describes the pharmacological effects of acetylcholine and atropine but is unrelated to vasomotor reversal of Dale.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D. Increase in blood pressure is produced by intravenous propranolol:</strong> Propranolol is a non-selective beta blocker that usually causes a decrease in blood pressure by blocking β1 and β2 receptors, leading to reduced cardiac output and vasodilation. This statement is incorrect and unrelated to vasomotor reversal of Dale.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The phenomenon of vasomotor reversal of Dale occurs when a patient pre-treated with an alpha blocker like phentolamine experiences severe hypotension upon administration of adrenaline due to the unopposed stimulation of β2 receptors, leading to vasodilation instead of the usual vasoconstriction and pressor effect.</span></p>",
      "correct_choice_id": 22018,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 29280,
      "choices": [
        {
          "id": 117026,
          "text": "<p><span style=\"font-size:12.0pt;\">It is approved for treatment of absent seizures</span></p>"
        },
        {
          "id": 117027,
          "text": "<p><span style=\"font-size:12.0pt;\">Fine tremors can be noted within therapeutic range</span></p>"
        },
        {
          "id": 117028,
          "text": "<p><span style=\"font-size:12.0pt;\">It does not cause teratogenicity</span></p>"
        },
        {
          "id": 117029,
          "text": "<p><span style=\"font-size:12.0pt;\">It is not absorbed orally</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following statements regarding lithium is correct?&nbsp;(INICET MAY 2023)</span></p>",
      "unique_key": "Q9655753",
      "question_audio": null,
      "question_video": null,
      "map_id": 15708919,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Fine tremors can be noted within therapeutic range</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lithium is a commonly used medication for the treatment of bipolar disorder, but it can cause fine tremors within the therapeutic range. The tremors are generally mild and not a significant side effect for most patients, but in some cases, they can be bothersome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. It is approved for treatment of absent seizures</strong>: This is incorrect. Lithium is not used for the treatment of absent seizures. It is primarily used in the management of bipolar disorder and sometimes for treatment-resistant depression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. It does not cause teratogenicity</strong>: This is incorrect. Lithium can cause teratogenic effects, particularly if used during the first trimester of pregnancy. It is associated with an increased risk of cardiac anomalies, such as Ebstein's anomaly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. It is not absorbed orally</strong>: This is incorrect. Lithium is well absorbed orally and reaches peak plasma concentrations within a few hours of ingestion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lithium, a medication commonly used for bipolar disorder, can cause fine tremors within the therapeutic range. It is well absorbed orally and has teratogenic potential, making it important to use with caution in pregnant women.</span></p>",
      "correct_choice_id": 117027,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54681,
      "choices": [
        {
          "id": 218189,
          "text": "<p><span style=\"font-size:12.0pt;\">Sevoflurane</span></p>"
        },
        {
          "id": 218190,
          "text": "<p><span style=\"font-size:12.0pt;\">Desflurane</span></p>"
        },
        {
          "id": 218191,
          "text": "<p><span style=\"font-size:12.0pt;\">Isoflurane</span></p>"
        },
        {
          "id": 218192,
          "text": "<p><span style=\"font-size:12.0pt;\">Halothane</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which inhaled anesthetic agent is preferred for pediatric induction of anesthesia? (INICET MAY 2024)</span></p>",
      "unique_key": "Q9833953",
      "question_audio": null,
      "question_video": null,
      "map_id": 15763968,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>A) Sevoflurane</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sevoflurane is the preferred inhaled anesthetic agent for the induction of anesthesia in pediatric patients. This is primarily due to its pleasant, sweet smell, which makes it more tolerable for children to inhale. Additionally, Sevoflurane has a rapid onset of action, meaning it works quickly to induce anesthesia. This quick induction is critical in pediatric patients who often do not have an intravenous (IV) line placed before induction. The ability to induce anesthesia effectively and without distress is a significant advantage in this age group.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Desflurane:</strong> Desflurane is not preferred for pediatric induction because it has a pungent odor, which can be irritating and unpleasant for children. Moreover, it can cause airway irritation, which is undesirable during induction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Isoflurane:</strong> While Isoflurane is effective as an anesthetic, it also has a pungent smell and slower onset of action compared to Sevoflurane, making it less ideal for pediatric use.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Halothane:</strong> Halothane was previously used for pediatric induction, but it has largely fallen out of favor due to its potential for causing liver toxicity and its slower onset of action compared to Sevoflurane.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Sevoflurane is the anesthetic agent of choice for inhalational induction in pediatric patients due to its sweet smell and rapid onset of action.</span></p>",
      "correct_choice_id": 218189,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54803,
      "choices": [
        {
          "id": 218677,
          "text": "<p><span style=\"font-size:12.0pt;\">Endotracheal intubation</span></p>"
        },
        {
          "id": 218678,
          "text": "<p><span style=\"font-size:12.0pt;\">To evaluate the risk of surgery</span></p>"
        },
        {
          "id": 218679,
          "text": "<p><span style=\"font-size:12.0pt;\">To evaluate the pros and cons of surgery</span></p>"
        },
        {
          "id": 218680,
          "text": "<p><span style=\"font-size:12.0pt;\">To evaluate the fitness of the patient</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the use of Mallampati classification?</span></p>",
      "unique_key": "Q2287147",
      "question_audio": null,
      "question_video": null,
      "map_id": 15764042,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Endotracheal intubation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Mallampati classification is a widely used clinical tool for predicting the ease of endotracheal intubation. This classification assesses the visibility of the structures at the back of the oropharynx. The patient is asked to open their mouth and protrude their tongue, and the visibility of the tonsillar pillars, uvula, and soft palate is observed.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Mallampati classes</strong>:</span><ul><li><span style=\"font-size:12.0pt;\"><strong>Class I</strong>: Full visibility of the tonsils, uvula, and soft palate.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Class II</strong>: Visibility of the uvula and soft palate.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Class III</strong>: Only the base of the uvula is visible.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Class IV</strong>: Only the hard palate is visible.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The higher the Mallampati score, the more difficult it may be to intubate the patient. Therefore, this classification is specifically used for evaluating the potential difficulty of airway management, particularly during endotracheal intubation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. To evaluate the risk of surgery</strong>: The evaluation of surgical risk is typically done using the ASA (American Society of Anesthesiologists) classification, not the Mallampati classification.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. To evaluate the pros and cons of surgery</strong>: This is a broad evaluation that involves multiple factors, including patient history and overall health, not just the airway assessment. The Mallampati classification is not relevant here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. To evaluate the fitness of the patient</strong>: General fitness or readiness for surgery involves various physiological and clinical assessments, but Mallampati classification is solely concerned with airway assessment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Mallampati classification is used to assess the difficulty of airway assessment, particularly for endotracheal intubation.</span></p>",
      "correct_choice_id": 218677,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31872,
      "choices": [
        {
          "id": 127358,
          "text": "<p><span style=\"font-size:12.0pt;\">Blockade of COX pathway</span></p>"
        },
        {
          "id": 127359,
          "text": "<p><span style=\"font-size:12.0pt;\">PG mediated bronchoconstriction</span></p>"
        },
        {
          "id": 127360,
          "text": "<p><span style=\"font-size:12.0pt;\">Augmentation of LOX pathway</span></p>"
        },
        {
          "id": 127361,
          "text": "<p><span style=\"font-size:12.0pt;\">Release of histamine</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A young female, who did not disclose her pre-existing history of asthma, presented to a hospital for the treatment of gout. She was given aspirin, after which an acute asthma attack was precipitated. What is the likely cause of bronchoconstriction in this patient? (FMGE July 2023)</span></p>",
      "unique_key": "Q9636084",
      "question_audio": null,
      "question_video": null,
      "map_id": 15708910,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Augmentation of LOX pathway</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The likely cause of bronchoconstriction in this patient is the augmentation of the LOX (lipoxygenase) pathway. Aspirin and other NSAIDs can cause bronchoconstriction in susceptible individuals by inhibiting the COX (cyclooxygenase) pathway. This shifts the arachidonic acid metabolism towards the LOX pathway, increasing the production of leukotrienes, potent bronchoconstrictors, which can precipitate asthma attacks.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option</strong> <strong>A.</strong> <strong>Blockade of COX pathway:</strong> While aspirin does block the COX pathway, the bronchoconstriction is more directly related to the subsequent augmentation of the LOX pathway.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option</strong> <strong>B. PG mediated bronchoconstriction:</strong> Prostaglandins generally have a bronchodilatory effect, so their inhibition by aspirin is not the primary cause of bronchoconstriction in this context.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D. Release of histamine:</strong> Histamine release is not the primary mechanism of aspirin-induced asthma, though it may play a role in allergic reactions.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Aspirin-induced bronchoconstriction in patients with asthma is primarily due to the augmentation of the LOX pathway, leading to increased production of leukotrienes, which are potent bronchoconstrictors.</span></p>",
      "correct_choice_id": 127360,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7029,
      "choices": [
        {
          "id": 28084,
          "text": "<p><span style=\"color:#333333;font-size:12pt;\">Hydrocortisone</span></p>"
        },
        {
          "id": 28085,
          "text": "<p><span style=\"color:#333333;font-size:12pt;\">Potassium binding resin</span></p>"
        },
        {
          "id": 28086,
          "text": "<p><span style=\"color:#333333;font-size:12pt;\">Digoxin</span></p>"
        },
        {
          "id": 28087,
          "text": "<p><span style=\"color:#333333;font-size:12pt;\">Calcium gluconate</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">An 18-month-old child with ambiguous genitalia presented to the hospital, his </span><span style=\"font-size:12.0pt;\">BP is 88/68 mm Hg</span><span style=\"font-size:12pt;\">, Serum K<sup>+</sup> is 6 mEq/L, serum sodium is 120 mEq/L. Patient was started on intravenous fluids. What additional specific therapy will you add?</span></p>",
      "unique_key": "Q9436180",
      "question_audio": null,
      "question_video": null,
      "map_id": 15708911,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A. Hydrocortisone</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The presentation of an 18-month-old child with ambiguous genitalia, hypertension (BP is 88/68 mm Hg, which is low for this age), hyperkalemia (serum K of 6 mEq/L), and hyponatremia (serum sodium of 120 mEq/L) is suggestive of congenital adrenal hyperplasia (CAH), most likely due to 21-hydroxylase deficiency. This is a common form of CAH and can lead to a decrease in cortisol and aldosterone production, with an accompanying increase in adrenal androgens.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Given this clinical picture, the specific therapy to be added would include:</span></p><p style=\"text-align:justify;\">&nbsp;</p><ol><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Glucocorticoid Replacement:</strong> This is critical to suppress the overproduction of adrenal androgens. Hydrocortisone is commonly used, especially in pediatric patients, due to its short duration of action and lower impact on growth.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Mineralocorticoid Replacement:</strong> Fludrocortisone is usually added to manage the aldosterone deficiency, which is contributing to the hyperkalemia and hyponatremia.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Sodium Chloride Supplements:</strong> In some cases, especially in infants and young children, additional sodium chloride supplements may be necessary to manage hyponatremia.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Monitoring and Adjustment:</strong> Regular monitoring of electrolytes, blood pressure, and growth is necessary to adjust therapy accordingly.</span></p></li></ol><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B</strong>. <strong>Potassium Binding Resins:</strong> While these can be used to treat hyperkalemia, they do not address the underlying cause of the electrolyte imbalance in this scenario, which is likely due to aldosterone deficiency. Therefore, it would not be the first choice.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C</strong>. <strong>Digoxin:</strong> This is used primarily for heart failure and certain arrhythmias, not for the conditions described in this scenario.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D</strong>. <strong>Calcium Gluconate:</strong> This is used in the acute management of severe hyperkalemia to stabilize cardiac membranes. While it might be used in an emergency setting for life-threatening hyperkalemia, it does not address the underlying cause in this case and is not a long-term management strategy.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Therefore, the most appropriate addition to this patient's treatment regimen would be <strong>Hydrocortisone</strong> (option a), as it addresses the underlying cause of the symptoms in CAH. Additionally, monitoring and adjusting mineralocorticoid therapy (like fludrocortisone) would be important in the long-term management, especially given the electrolyte imbalances.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The most appropriate addition to this patient's treatment regimen would be Hydrocortisone, as it addresses the underlying cause of the symptoms in CAH. Additionally, monitoring and adjusting mineralocorticoid therapy (like fludrocortisone) would be important in the long-term management, especially given the electrolyte imbalances.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Reference: - KDT 8<sup>TH</sup>/314</strong></span></p>",
      "correct_choice_id": 28084,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 65726,
      "choices": [
        {
          "id": 262069,
          "text": "<p><span style=\"font-size:12.0pt;\">SGLT2 inhibitors&nbsp;</span></p>"
        },
        {
          "id": 262070,
          "text": "<p><span style=\"font-size:12.0pt;\">DPP4 inhibitors&nbsp;</span></p>"
        },
        {
          "id": 262071,
          "text": "<p><span style=\"font-size:12.0pt;\">Sulfonylureas&nbsp;</span></p>"
        },
        {
          "id": 262072,
          "text": "<p><span style=\"font-size:12.0pt;\">Thiazolidinediones</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 52-year-old patient with newly diagnosed type 2 diabetes mellitus presents with an HbA1c of 8.2%. The patient has normal renal function but a strong family history of diabetic nephropathy. Which of the following drugs should be initiated first to prevent future renal complications? (Twisted PYQ)</span></p>",
      "unique_key": "Q9297415",
      "question_audio": null,
      "question_video": null,
      "map_id": 15754958,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) SGLT2 inhibitors</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">SGLT2 inhibitors have demonstrated significant primary prevention of diabetic kidney disease.</span></li><li><span style=\"font-size:12.0pt;\">They reduce hyperfiltration and oxidative stress in the kidneys even before the onset of albuminuria.</span></li><li><span style=\"font-size:12.0pt;\">Recent guidelines recommend early initiation of SGLT2 inhibitors in high-risk patients for primary prevention of diabetic kidney disease.</span></li><li><span style=\"font-size:12.0pt;\">They also provide cardiovascular benefits and are weight neutral or promote weight loss.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. DPP4 inhibitors</strong>: While these are safe in renal impairment, they have not shown significant primary prevention benefits for diabetic kidney disease. Their effect on renal outcomes is neutral.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Sulfonylureas</strong>: These medications, while effective for glucose control, do not offer specific renoprotective benefits. They are associated with weight gain and hypoglycemia risk, which may indirectly impact renal outcomes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Thiazolidinediones</strong>: Although they may reduce albuminuria to some extent, their primary prevention benefits for diabetic kidney disease are not as robust as SGLT2 inhibitors. They are associated with fluid retention and weight gain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Early intervention with medications that have proven renoprotective benefits is crucial in high-risk diabetic patients. SGLT2 inhibitors have emerged as first-line agents not only for glycemic control but also for primary prevention of diabetic kidney disease, especially in patients with risk factors for renal complications.</span></p>",
      "correct_choice_id": 262069,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54801,
      "choices": [
        {
          "id": 218669,
          "text": "<p><span style=\"font-size:12.0pt;\">15:2</span></p>"
        },
        {
          "id": 218670,
          "text": "<p><span style=\"font-size:12.0pt;\">30:2</span></p>"
        },
        {
          "id": 218671,
          "text": "<p><span style=\"font-size:12.0pt;\">15:1</span></p>"
        },
        {
          "id": 218672,
          "text": "<p><span style=\"font-size:12.0pt;\">30:1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the compression to ventilation ratio in an adult cardiac arrest patient in the presence of more than one rescuer?</span></p>",
      "unique_key": "Q2916855",
      "question_audio": null,
      "question_video": null,
      "map_id": 15763959,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B) 30:2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In adult patients experiencing cardiac arrest, the recommended compression to ventilation ratio during CPR is 30:2, regardless of the number of rescuers present. This ratio ensures that adequate chest compressions are delivered to maintain blood circulation while allowing time for sufficient ventilation to oxygenate the blood. The priority in adult CPR is effective chest compressions, which is why the ratio is set to 30 compressions for every 2 ventilations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This ratio remains constant irrespective of whether there is one rescuer or more than one, ensuring consistency and simplicity during the resuscitation process.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For adult CPR, regardless of the number of rescuers, the compression to ventilation ratio should always be 30:2 to ensure effective circulation and oxygenation during cardiac arrest.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Additionally, <strong>For children&nbsp;</strong>with one rescuer, the ratio is <strong>30 compressions to 2 ventilations (30:2)</strong>; with two rescuers, the ratio is <strong>15 compressions to 2 ventilations (15:2)</strong>. <strong>For neonates</strong>, the ratio is <strong>3 compressions to 1 ventilation (3:1)</strong>.</span></p>",
      "correct_choice_id": 218670,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6437,
      "choices": [
        {
          "id": 25717,
          "text": "<p><span style=\"font-size:12.0pt;\">Probenecid</span></p>"
        },
        {
          "id": 25718,
          "text": "<p><span style=\"font-size:12.0pt;\">Diazepam</span></p>"
        },
        {
          "id": 25719,
          "text": "<p><span style=\"font-size:12.0pt;\">Haloperidol</span></p>"
        },
        {
          "id": 25720,
          "text": "<p><span style=\"font-size:12.0pt;\">Sodium valproate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which is the drug used for refractory intractable rheumatic chorea?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2018)</span></p>",
      "unique_key": "Q1042326",
      "question_audio": null,
      "question_video": null,
      "map_id": 15708907,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"margin-left:0px;\"><span style=\"font-size:14px;\"><strong>Ans. D) Sodium valproate</strong></span></p><p style=\"margin-left:0px;\">&nbsp;</p><p style=\"margin-left:0px;\"><span style=\"font-size:14px;\">Sodium valproate is the drug used for refractory intractable rheumatic chorea. It's an anticonvulsant medication that has proven effective in managing the involuntary movements associated with this condition. It works primarily by enhancing the effects of gamma-aminobutyric acid (GABA) in the brain, which helps reduce abnormal electrical activity.</span></p><p style=\"margin-left:0px;\">&nbsp;</p><p style=\"margin-left:0px;\"><span style=\"font-size:14px;\"><strong>Other Options:</strong></span></p><p style=\"margin-left:0px;\">&nbsp;</p><p style=\"margin-left:0px;\"><span style=\"font-size:14px;\"><strong>Option A. Probenecid:</strong> Probenecid is a medication used primarily to treat gout by reducing the levels of uric acid in the blood. It is not used for the treatment of rheumatic chorea.</span></p><p style=\"margin-left:0px;\">&nbsp;</p><p style=\"margin-left:0px;\"><span style=\"font-size:14px;\"><strong>Option B. Diazepam:</strong> Diazepam is a benzodiazepine used to treat anxiety, muscle spasms, and seizures. While it can provide muscle relaxation and sedation, it is not the drug of choice for managing refractory rheumatic chorea.</span></p><p style=\"margin-left:0px;\">&nbsp;</p><p style=\"margin-left:0px;\"><span style=\"font-size:14px;\"><strong>Option C. Haloperidol:</strong> Haloperidol is an antipsychotic medication that can be used in some movement disorders. While it has been used in chorea, it is not considered the optimal treatment for refractory intractable rheumatic chorea due to its side effect profile and efficacy compared to sodium valproate.</span></p><p style=\"margin-left:0px;\">&nbsp;</p><p style=\"margin-left:0px;\"><span style=\"font-size:14px;\"><strong>Educational Objective:</strong></span></p><p style=\"margin-left:0px;\">&nbsp;</p><p style=\"margin-left:0px;\"><span style=\"font-size:14px;\">Sodium valproate is the preferred drug for treating refractory intractable rheumatic chorea due to its efficacy in reducing involuntary movements by enhancing inhibitory neurotransmission in the brain. It has a better side effect profile for long-term management of this condition compared to other options.</span></p>",
      "correct_choice_id": 25720,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1025,
      "choices": [
        {
          "id": 4096,
          "text": "<p><span style=\"font-size:12pt;\">Thermal dilution technique</span></p>"
        },
        {
          "id": 4097,
          "text": "<p><span style=\"font-size:12pt;\">Capnography</span></p>"
        },
        {
          "id": 4098,
          "text": "<p><span style=\"font-size:12pt;\">Esophageal doppler</span></p>"
        },
        {
          "id": 4099,
          "text": "<p><span style=\"font-size:12pt;\">Echocardiography</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Cardiac output can be determined using the following except? (</span>INICET May 2020)</p>",
      "unique_key": "Q2739952",
      "question_audio": null,
      "question_video": null,
      "map_id": 15763961,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Capnography&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Function:</strong> Capnography primarily measures the concentration of carbon dioxide (CO2) in exhaled air, which gives information about ventilation and metabolism.</span></li><li><span style=\"font-size:12pt;\"><strong>Usage:</strong> It is used to confirm tracheal intubation and monitor ventilation status but does not measure cardiac output.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Thermal dilution technique:&nbsp;</strong>The thermal dilution technique is a method used primarily with a pulmonary artery catheter (also known as a Swan-Ganz catheter). Cold saline is injected into the right atrium, and the change in blood temperature is measured as it passes a thermistor in the pulmonary artery. The degree of temperature change allows for the calculation of cardiac output. This method is invasive and provides continuous or intermittent measurements, depending on the specific catheter and monitor used.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Esophageal Doppler:&nbsp;</strong>The esophageal Doppler uses ultrasound waves to measure blood flow velocity in the descending aorta via a probe placed in the esophagus. By knowing the cross-sectional area of the aorta and calculating the velocity of blood flow, cardiac output can be estimated.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Echocardiography:&nbsp;</strong>Echocardiography, or cardiac ultrasound, allows for visualization of cardiac structures and blood flow. Cardiac output can be estimated by measuring the velocity of blood flow across the mitral or tricuspid valves and then multiplying this by the valve area.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Capnography is used to measure end-tidal CO2 and confirm tracheal intubation but is not used to determine cardiac output. Cardiac output can be measured using invasive methods such as the thermal dilution technique and non-invasive methods such as esophageal Doppler and echocardiography.</span></li></ul>",
      "correct_choice_id": 4097,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4489,
      "choices": [
        {
          "id": 17932,
          "text": "<p><span style=\"font-size:12pt;\">EEG</span></p>"
        },
        {
          "id": 17933,
          "text": "<p><span style=\"font-size:12pt;\">Provoked lower esophageal contractility</span></p>"
        },
        {
          "id": 17934,
          "text": "<p><span style=\"font-size:12pt;\">Entropy</span></p>"
        },
        {
          "id": 17935,
          "text": "<p><span style=\"font-size:12pt;\">Bispectral index</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which among the following monitors is most commonly used to monitor the depth of anesthesia?</span></p>",
      "unique_key": "Q4781627",
      "question_audio": null,
      "question_video": null,
      "map_id": 15763965,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Bispectral index</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>The bispectral index</strong> (BIS) is the most commonly used method to monitor the depth of anesthesia and determine the level of consciousness under anesthesia.</span></li><li><span style=\"font-size:12pt;\">BIS is derived from the EEG (electroencephalogram) and shows the cerebral drug effect of an anesthetic drug.</span></li><li><span style=\"font-size:12pt;\">BIS values range from 0-100, where lower values indicate deeper anesthesia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. EEG:&nbsp;</strong>While EEG is the basis for BIS, it is not typically used directly in clinical practice to monitor anesthesia depth due to its complexity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Provoked lower esophageal contractility:&nbsp;</strong>This is not a standard or common method for monitoring the depth of anesthesia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Entropy:&nbsp;</strong>Entropy monitoring is another EEG-based technique used to assess the depth of anesthesia. However, it is less commonly used compared to BIS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The bispectral index (BIS) is the most commonly used monitor to assess the depth of anesthesia, providing an EEG-derived measure of the cerebral effects of anesthetic drugs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/23/picture70_8iI3h7S.jpg\" alt=\"\" width=\"1000\" height=\"207\"></span></p>",
      "correct_choice_id": 17935,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InstrumentsBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4527,
      "choices": [
        {
          "id": 18084,
          "text": "<p><span style=\"font-size:12.0pt;\">Head tilt, chin lift</span></p>"
        },
        {
          "id": 18085,
          "text": "<p><span style=\"font-size:12.0pt;\">Jaw thrust</span></p>"
        },
        {
          "id": 18086,
          "text": "<p><span style=\"font-size:12.0pt;\">Head extension</span></p>"
        },
        {
          "id": 18087,
          "text": "<p><span style=\"font-size:12.0pt;\">In line manual stabilization</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What is the maneuver being performed in the given image? (NEET PG 2021)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/05/screenshot-2024-07-05-172225.png\" alt=\"\" width=\"300\" height=\"260\"></p>",
      "unique_key": "Q3440409",
      "question_audio": null,
      "question_video": null,
      "map_id": 15763963,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Head tilt, chin lift</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The maneuver being performed in the given image is that of head-tilt chin-lift.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">It is an airway management technique to open up the collapsed airway.</span></li><li><span style=\"font-size:12.0pt;\">This maneuver involves tilting the patient's head backward by gently lifting the chin upward.</span></li><li><span style=\"font-size:12.0pt;\">It is used to open the airway and clear any potential obstruction in the upper part of the throat.</span></li><li><span style=\"font-size:12.0pt;\">This is a basic technique used in CPR (Cardiopulmonary Resuscitation) to help with ventilation.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/23/picture74.jpg\" alt=\"\" width=\"400\" height=\"374\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Jaw thrust:</strong> The jaw thrust maneuver is used to open the airway in a patient with a suspected cervical spine injury. Instead of tilting the head backward, the anesthesiologist uses their fingers to push the patient's jaw forward. This technique avoids movement of the neck and is often used when spinal injury is a concern.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/23/picture75.jpg\" alt=\"\" width=\"400\" height=\"366\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Head extension:</strong> Head extension involves simply tilting the patient's head backward to open the airway. It is similar to the head tilt, chin lift maneuver, but it focuses more on extending the neck to clear the airway.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/23/picture76.jpg\" alt=\"\" width=\"400\" height=\"242\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. In line manual stabilization:</strong> This technique is used to stabilize the cervical spine, especially in cases of suspected neck injuries. It involves maintaining the head and neck in a neutral, aligned position to prevent further injury during maneuvers like intubation. This is typically done by an assistant while another healthcare provider performs airway management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/23/picture77.jpg\" alt=\"\" width=\"400\" height=\"245\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The maneuver being performed in the given image is that of head-tilt chin-lift.</span></li><li><span style=\"font-size:12.0pt;\">It is an airway management technique to open up the collapsed airway.</span></li></ul>",
      "correct_choice_id": 18084,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57494,
      "choices": [
        {
          "id": 229349,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Prevents atelectasis of lung and alveolar collapse </span></span></span></p>"
        },
        {
          "id": 229350,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Reduces CO2 in alveoli</span></span></span></p>"
        },
        {
          "id": 229351,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decreases inspiratory pressure</span></span></span></p>"
        },
        {
          "id": 229352,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increases venous return and thus maintains cardiac output</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a patient on mechanical ventilation and placed in prone position which of the following about PEEP is true? (NEET PG 2024)</span></span></p>",
      "unique_key": "Q8648617",
      "question_audio": null,
      "question_video": null,
      "map_id": 15764041,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Prevents atelectasis of lung and alveolar collapse </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Positive End-Expiratory Pressure (PEEP) is a crucial component of mechanical ventilation, particularly in patients with acute respiratory distress syndrome (ARDS) or other conditions leading to alveolar collapse. PEEP works by maintaining a certain amount of pressure in the lungs at the end of expiration, which helps to keep the alveoli open, preventing their collapse (atelectasis). This is especially important in the prone position, where the distribution of ventilation can be more uniform, improving oxygenation and lung mechanics.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Reduces CO2 in alveoli:</span></strong><span style=\"font-size:12.0pt\"> This option is incorrect because the primary role of PEEP is not to reduce CO2 levels in the alveoli but to prevent alveolar collapse and improve oxygenation. CO2 removal is more dependent on ventilation rate and tidal volume.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Decreases inspiratory pressure:</span></strong><span style=\"font-size:12.0pt\"> This option is incorrect because PEEP typically increases the baseline pressure in the lungs, which can actually increase the overall mean airway pressure during inspiration. It does not decrease inspiratory pressure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Increases venous</span></strong> <strong><span style=\"font-size:12.0pt\">return and thus maintains cardiac output:</span></strong><span style=\"font-size:12.0pt\"> This option is incorrect because, in fact, PEEP can decrease venous return due to the increased intrathoracic pressure it creates. This decrease in venous return can lead to a reduction in cardiac output, especially in patients with pre-existing cardiovascular compromise.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">PEEP is primarily used to prevent alveolar collapse (atelectasis) and maintain lung recruitment, especially in conditions like ARDS or when the patient is positioned prone during mechanical ventilation.</span></span></span></p>",
      "correct_choice_id": 229349,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57295,
      "choices": [
        {
          "id": 228557,
          "text": "<p><span style=\"font-size:12pt;\">It is an Equal Mixture of Local Anesthetics</span></p>"
        },
        {
          "id": 228558,
          "text": "<p><span style=\"font-size:12pt;\">It contains lignocaine and ropivacaine in a ratio of 50 percent each</span></p>"
        },
        {
          "id": 228559,
          "text": "<p><span style=\"font-size:12pt;\">Excessive use can result in methemoglobinemia</span></p>"
        },
        {
          "id": 228560,
          "text": "<p><span style=\"font-size:12pt;\">5 ml of 5 percent mixture contains 50 mg lignocaine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following statements regarding the patch used in the given figure is correct? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-184820.jpg\" alt=\"\" width=\"400\" height=\"272\"></span></p>",
      "unique_key": "Q6801604",
      "question_audio": null,
      "question_video": null,
      "map_id": 15708915,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Excessive use can result in methemoglobinemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The patch in the image is an EMLA patch, which stands for Eutectic Mixture of Local Anesthetics. It is commonly used to numb the skin before procedures like needle insertions. The EMLA patch contains a mixture of two local anesthetics: lignocaine (also known as lidocaine) and prilocaine, each at a concentration of 2.5%.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">One of the known side effects of prilocaine, especially when used in excessive amounts, is the risk of methemoglobinemia. This condition occurs when hemoglobin is converted to methemoglobin, which cannot effectively release oxygen to body tissues. Although the risk is generally low, it can be significant in infants and other at-risk populations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. It is an Equal Mixture of Local Anesthetics:</strong> This statement is misleading. While the mixture contains equal concentrations of lignocaine and prilocaine (2.5% each), the term \"eutectic\" is key, indicating that the two anesthetics lower each other's melting points when combined, creating a mixture that is liquid at room temperature. The emphasis should be on the \"eutectic\" nature rather than just being an \"equal mixture.\"</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. It contains lignocaine and ropivacaine in a ratio of 50 percent each:</strong> This is incorrect because the EMLA patch contains lignocaine and prilocaine, not ropivacaine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. 5 ml of 5 percent mixture contains 50 mg lignocaine:</strong> This calculation is incorrect. A 5% solution means 5 g of the drug is present in 100 ml of solution, which translates to 50 mg/ml. Therefore, 5 ml of the mixture would contain 250 mg of lignocaine, not 50 mg.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Prilocaine, one of the components of the EMLA patch, can cause methemoglobinemia, especially when used in excessive amounts or in vulnerable populations like infants.</span></p>",
      "correct_choice_id": 228559,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57457,
      "choices": [
        {
          "id": 229201,
          "text": "<p><span style=\"font-size:12.0pt;\">Oropharyngeal airway</span></p>"
        },
        {
          "id": 229202,
          "text": "<p><span style=\"font-size:12.0pt;\">Ovassapian airway</span></p>"
        },
        {
          "id": 229203,
          "text": "<p><span style=\"font-size:12.0pt;\">Nasopharyngeal airway</span></p>"
        },
        {
          "id": 229204,
          "text": "<p><span style=\"font-size:12.0pt;\">Uncuffed endotracheal tube</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the instrument: (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/18/screenshot-2024-09-17-183434.jpg\" alt=\"\" width=\"400\" height=\"294\"></span></p>",
      "unique_key": "Q8476118",
      "question_audio": null,
      "question_video": null,
      "map_id": 15763958,
      "difficulty_level": "intermediate",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Nasopharyngeal airway</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The instrument shown in the image is a nasopharyngeal airway (NPA). This is a flexible, soft tube that is inserted through the nostril into the nasopharynx to secure an open airway. NPAs are particularly useful in situations where the patient is conscious or semi-conscious and may not tolerate an oropharyngeal airway due to a gag reflex. It is also useful when the oral route is not accessible or practical.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Oropharyngeal airway:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/18/whatsapp-image-2024-09-17-at-190425.jpeg\" alt=\"\" width=\"400\" height=\"273\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ovassapian airway:&nbsp;</strong> The Ovassapian airway is a specific type of oropharyngeal airway designed for fiberoptic intubation.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/18/screenshot-2024-09-17-185236.jpg\" alt=\"\" width=\"400\" height=\"126\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Uncuffed endotracheal tube</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/18/screenshot-2024-09-17-185313.jpg\" alt=\"\" width=\"400\" height=\"219\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The nasopharyngeal airway (NPA) is a flexible tube used to secure an airway via the nasal passage, especially in patients who are semi-conscious and have an intact gag reflex.</span></p>",
      "correct_choice_id": 229203,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/57457/Neet_Pg_Aug_2024_Anesthesia_Q_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ImageBased",
        "InstrumentsBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/57457/Neet_Pg_Aug_2024_Anesthesia_Q_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 65729,
      "choices": [
        {
          "id": 262081,
          "text": "<p><span style=\"font-size:12.0pt;\">Aztreonam</span></p>"
        },
        {
          "id": 262082,
          "text": "<p><span style=\"font-size:12.0pt;\">Vancomycin</span></p>"
        },
        {
          "id": 262083,
          "text": "<p><span style=\"font-size:12.0pt;\">Ceftriaxone</span></p>"
        },
        {
          "id": 262084,
          "text": "<p><span style=\"font-size:12.0pt;\">Piperacillin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old patient with a known allergy to penicillin presents with a gram-negative bacteremia caused by <i>Pseudomonas aeruginosa</i>. The physician wants to prescribe an antibiotic that is safe for a patient with a penicillin allergy. Which of the following drugs is the most appropriate choice? <i>(Twisted PYQ)</i></span></p>",
      "unique_key": "Q2765289",
      "question_audio": null,
      "question_video": null,
      "map_id": 15754960,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Aztreonam</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Aztreonam is a monobactam antibiotic that is specifically effective against gram-negative bacteria, including Pseudomonas aeruginosa. It is structurally distinct from penicillins and cephalosporins, making it a safe option for patients with penicillin allergies. Aztreonam does not cover gram-positive bacteria, but for this scenario involving Pseudomonas aeruginosa (a gram-negative organism), it is highly effective.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Vancomycin:</strong> Incorrect because vancomycin is effective only against gram-positive bacteria and would not treat a gram-negative infection like Pseudomonas aeruginosa.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C Ceftriaxone:</strong> Incorrect because, while ceftriaxone can be used for certain gram-negative infections, caution is advised in patients with severe penicillin allergies due to the risk of cross-reactivity. Furthermore, ceftriaxone has limited activity against Pseudomonas aeruginosa.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Piperacillin:</strong> Incorrect because it is a penicillin derivative and contraindicated in patients with penicillin allergies due to a high risk of allergic reactions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Aztreonam is a safe and effective option for treating gram-negative infections in patients with penicillin allergies, particularly when dealing with Pseudomonas aeruginosa</span></p>",
      "correct_choice_id": 262081,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 35038,
      "choices": [
        {
          "id": 139963,
          "text": "<p><span style=\"font-size:12pt;\">OSA</span></p>"
        },
        {
          "id": 139964,
          "text": "<p><span style=\"font-size:12pt;\">Unconscious patient</span></p>"
        },
        {
          "id": 139965,
          "text": "<p><span style=\"font-size:12pt;\">High CO<sub>2</sub></span></p>"
        },
        {
          "id": 139966,
          "text": "<p><span style=\"font-size:12pt;\">Low oxygen</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of these is a contraindication to the use of BiPAP ?&nbsp;</span>(FMGE JANUARY 2024)</p>",
      "unique_key": "Q1946193",
      "question_audio": null,
      "question_video": null,
      "map_id": 15764010,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Unconscious patient</strong></span></p><p>&nbsp;</p><p><span style=\"color:#0f4761;font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">BiPAP, or Bilevel Positive Airway Pressure, is a non-invasive ventilation method that provides two levels of pressure: higher inspiratory positive airway pressure (IPAP) and lower expiratory positive airway pressure (EPAP). It is commonly used in various respiratory conditions but has contraindications. An unconscious patient may not be able to protect their airway, which increases the risk of aspiration. Such patients are typically not candidates for non-invasive ventilation like BiPAP.</span></p><p>&nbsp;</p><p><span style=\"color:#0f4761;font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. OSA (Obstructive Sleep Apnea):</strong> BiPAP can be used as a treatment for OSA to prevent airway collapse during sleep.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. High CO2 (Hypercapnia):</strong> BiPAP is often used for hypercapnic respiratory failure because it can help blow off excess CO2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Low Oxygen (Hypoxemia):</strong> While BiPAP can help improve oxygenation by increasing the alveolar ventilation, it may not be sufficient in cases of severe hypoxemia where invasive ventilation might be necessary.</span></p><p>&nbsp;</p><p><span style=\"color:#0f4761;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">BiPAP is contraindicated in unconscious patients due to the increased risk of aspiration and inability to protect their airway.</span></p>",
      "correct_choice_id": 139964,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/35038/FMGE_Jan_-_2024_Anesthesia_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "CriteriaBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/35038/FMGE_Jan_-_2024_Anesthesia_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6944,
      "choices": [
        {
          "id": 27744,
          "text": "<p><span style=\"font-size:12.0pt;\">Cimetidine</span></p>"
        },
        {
          "id": 27745,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbamazepine</span></p>"
        },
        {
          "id": 27746,
          "text": "<p><span style=\"font-size:12.0pt;\">Isoniazid</span></p>"
        },
        {
          "id": 27747,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drugs does not increase the risk of bleeding in patients undergoing warfarin therapy?</span></p>",
      "unique_key": "Q6679185",
      "question_audio": null,
      "question_video": null,
      "map_id": 15708916,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Carbamazepine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Warfarin is an anticoagulant that is metabolized primarily by the CYP2C9 enzyme. The risk of bleeding with warfarin therapy is influenced by drugs that either inhibit or induce the metabolism of warfarin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Carbamazepine, is an enzyme inducer. It induces CYP450 enzymes, including CYP2C9, which increases the metabolism of warfarin, leading to reduced plasma warfarin levels and a decreased anticoagulant effect. Therefore, carbamazepine does not increase the risk of bleeding; instead, it can reduce the effectiveness of warfarin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cimetidine:&nbsp;</strong>Cimetidine is a known inhibitor of the CYP450 enzymes, including CYP2C9. By inhibiting this enzyme, cimetidine reduces the metabolism of warfarin, leading to higher plasma concentrations of warfarin and an increased risk of bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Isoniazid:&nbsp;</strong>Isoniazid is an inhibitor of several CYP450 enzymes, including CYP2C9. This inhibition can lead to decreased metabolism of warfarin, increased plasma warfarin levels, and a higher risk of bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Amiodarone:&nbsp;</strong>Amiodarone is a potent inhibitor of CYP2C9. It reduces the metabolism of warfarin, resulting in elevated levels of warfarin in the blood and an increased risk of bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Warfarin is mainly metabolized by the CYP2C9 enzyme. Drugs like Cimetidine, Isoniazid, Amiodarone, Clopidogrel, Ketoconazole, Verapamil etc inhibit the enzyme, thus reducing the metabolism of warfarin. This increases the plasma concentration of Warfarin and leads to increased risk of bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Carbamazepine is an enzyme inducer and increases the metabolism of warfarin leading to decrease in effect of warfarin.</span></p>",
      "correct_choice_id": 27745,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43258,
      "choices": [
        {
          "id": 172699,
          "text": "<p><span style=\"font-size:12pt;\">25%</span></p>"
        },
        {
          "id": 172700,
          "text": "<p><span style=\"font-size:12pt;\">&nbsp;30%</span></p>"
        },
        {
          "id": 172701,
          "text": "<p><span style=\"font-size:12pt;\">&nbsp;40%</span></p>"
        },
        {
          "id": 172702,
          "text": "<p><span style=\"font-size:12pt;\">&nbsp;45%</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A child was being delivered oxygen by nasal canula at 3L/min. What is the FiO2 being delivered?</span><span style=\"font-size:12.0pt;\">&nbsp;</span>&nbsp;(INICET NOVEMBER 2023)</p>",
      "unique_key": "Q8086256",
      "question_audio": null,
      "question_video": null,
      "map_id": 15764014,
      "difficulty_level": "intermediate",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B.&nbsp; 30%</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The fraction of inspired oxygen (FiO2) delivered by nasal cannula increases by approximately 4% for every 1 liter per minute of oxygen flow. Thus:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">1 L/min would raise the FiO2 to about 24%.</span></li><li><span style=\"font-size:12pt;\">2 L/min would be about 28%.</span></li><li><span style=\"font-size:12pt;\">3 L/min would be about 32%.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Given the options provided, the closest and most commonly accepted approximation for the FiO2 being delivered at a flow rate of 3 L/min through a nasal cannula would be around 30%.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;A. 25%:</strong> This FiO2 would typically correspond to an oxygen flow rate of about 1 L/min via nasal cannula.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;C. 40%:</strong> This FiO2 would typically correspond to an oxygen flow rate of about 5 L/min via nasal cannula.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;D. 45%:</strong> This FiO2 would typically correspond to an oxygen flow rate of about 6 L/min via nasal cannula.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The FiO2 delivered by a nasal cannula at a flow rate of 3 L/min is approximately 30%.</span></p>",
      "correct_choice_id": 172700,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33863,
      "choices": [
        {
          "id": 135290,
          "text": "<p><span style=\"font-size:12.0pt;\">Acarbose</span></p>"
        },
        {
          "id": 135291,
          "text": "<p><span style=\"font-size:12.0pt;\">Glipizide</span></p>"
        },
        {
          "id": 135292,
          "text": "<p><span style=\"font-size:12.0pt;\">Empagliflozin</span></p>"
        },
        {
          "id": 135293,
          "text": "<p><span style=\"font-size:12.0pt;\">Sitagliptin</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 53-year-old male presented with type 2 diabetes mellitus. Which of the following anti-diabetic drug acts by causing glucosuria?</span> <span style=\"font-size:12.0pt;\">(Fmge Jan 2024)</span></p>",
      "unique_key": "Q8481318",
      "question_audio": null,
      "question_video": null,
      "map_id": 15708923,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Empagliflozin</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Empagliflozin, as an SGLT2 inhibitor, is the drug among the options provided that acts specifically by causing glucosuria. This mechanism is unique to SGLT2 inhibitors and is a direct way of lowering blood glucose levels in type 2 diabetes mellitus. The other drugs listed work through different mechanisms that do not involve the induction of glucosuria.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A.</strong> <strong>Acarbose:</strong> This drug is an alpha-glucosidase inhibitor. It works by slowing down the digestion of carbohydrates in the intestine, thereby reducing the rise in blood glucose after meals. It does not cause glucosuria.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B.</strong> <strong>Glipizide:</strong> Glipizide is a sulfonylurea. It works by stimulating insulin release from the pancreatic beta cells. It does not cause glucosuria.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D.</strong> <strong>Sitagliptin:</strong> Sitagliptin is a DPP-4 inhibitor. It works by increasing the levels of incretin hormones, which increase insulin release and decrease glucagon release in a glucose-dependent manner. It does not cause glucosuria.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Empagliflozin is an SGLT2 (Sodium-Glucose Co-Transporter-2) inhibitor, works by blocking glucose reabsorption in the kidney, leading to increased glucose excretion in the urine, i.e., glucosuria.</span></p>",
      "correct_choice_id": 135292,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6946,
      "choices": [
        {
          "id": 27752,
          "text": "<p><span style=\"font-size:12.0pt;\">Dexamethasone</span></p>"
        },
        {
          "id": 27753,
          "text": "<p><span style=\"font-size:12.0pt;\">Digoxin</span></p>"
        },
        {
          "id": 27754,
          "text": "<p><span style=\"font-size:12.0pt;\">Diltiazem</span></p>"
        },
        {
          "id": 27755,
          "text": "<p><span style=\"font-size:12.0pt;\">Acetazolamide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is used in acute mountain sickness?</span></p>",
      "unique_key": "Q1634633",
      "question_audio": null,
      "question_video": null,
      "map_id": 15708925,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Acetazolamide</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acetazolamide is the drug of choice for acute mountain sickness. Rapid ascent to high altitudes can lead to the development of headache, nausea, vomiting, dizziness, breathlessness etc. The underlying cause that has been implicated in its causation is cerebral edema. The low PO2 at high altitude causes arteriolar dilation, and if cerebral autoregulation does not compensate, there is an increase in capillary pressure that favors increased transudation of fluid into brain tissue leading to cerebral edema.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acetazolamide is a carbonic anhydrase inhibitor that leads to metabolic acidosis, which in turn stimulates hyperventilation, leading to CO2 washout, and it helps in reducing the formation of CSF.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Dexamethasone:&nbsp;</strong>Dexamethasone is a corticosteroid and can be used as a treatment for cerebral edema and severe cases of AMS. However, it is not the first-line drug of choice for general AMS prevention or mild cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Digoxin:&nbsp;</strong>Digoxin is a cardiac glycoside used primarily for heart conditions such as atrial fibrillation and heart failure. It has no role in the prevention or treatment of acute mountain sickness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Diltiazem:&nbsp;</strong>Diltiazem is a calcium channel blocker used for treating hypertension and angina. It is not used in the management of acute mountain sickness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acetazolamide is the drug of choice for acute mountain sickness because it induces metabolic acidosis and stimulates hyperventilation, helping to improve oxygenation and reduce cerebral edema.</span></p>",
      "correct_choice_id": 27755,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31873,
      "choices": [
        {
          "id": 127362,
          "text": "<p><span style=\"font-size:12pt;\">8 mg</span></p>"
        },
        {
          "id": 127363,
          "text": "<p><span style=\"font-size:12pt;\">15 mg</span></p>"
        },
        {
          "id": 127364,
          "text": "<p><span style=\"font-size:12pt;\">20 mg</span></p>"
        },
        {
          "id": 127365,
          "text": "<p><span style=\"font-size:12pt;\">40 mg</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 70-year-old male arrives at the emergency department with symptoms indicative of an acute ischemic stroke. It is decided to administer recombinant tissue plasminogen activator (rtPA), with a total dose of 80 mg. How much should be given as the initial bolus dose? (FMGE July 2023)</span></p>",
      "unique_key": "Q4842214",
      "question_audio": null,
      "question_video": null,
      "map_id": 15708920,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) 8 mg</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">For the administration of recombinant tissue plasminogen activator (rtPA) in acute ischemic stroke, the initial bolus dose should be 10% of the total dose. Therefore, for a total dose of 80 mg, the initial bolus dose should be 8 mg (which is 10% of 80 mg).</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">When administering rtPA for acute ischemic stroke, the initial bolus dose should be 10% of the total dose. For an 80 mg total dose, the initial bolus is 8 mg, followed by an infusion of the remaining dose over 60 minutes.</span></p>",
      "correct_choice_id": 127362,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1031,
      "choices": [
        {
          "id": 4120,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Block sodium channels</span></span></span></p>"
        },
        {
          "id": 4121,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Block potassium channels</span></span></span></p>"
        },
        {
          "id": 4122,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Block calcium channels</span></span></span></p>"
        },
        {
          "id": 4123,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Block chloride channels</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the mechanism of action of local anesthetics?</span></span></span></p>",
      "unique_key": "Q6214791",
      "question_audio": null,
      "question_video": null,
      "map_id": 15764043,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Block sodium channels </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mechanism:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Local anesthetics primarily act by blocking the sodium channels bound to the membrane of the nerve, thus inhibiting sodium influx into the nerve and avoiding depolarization of the nerve.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">States of Sodium Channels:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The voltage-gated sodium channels exist in three states:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Resting (non-conducting)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Open (conducting)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inactivated (non-conducting)</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Affinity:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Local anesthetics have maximum affinity for the sodium channels in the inactivated state.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Block potassium channels:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blocking potassium channels is not the primary mechanism of action for local anesthetics. Potassium channels are more involved in the repolarization phase of the action potential.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Block calcium channels:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blocking calcium channels is not the primary mechanism of action for local anesthetics. Calcium channels are more involved in neurotransmitter release at synapses.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Block chloride channels:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blocking chloride channels is not the primary mechanism of action for local anesthetics. Chloride channels are typically associated with inhibitory neurotransmission.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Local anesthetics work by blocking voltage-gated sodium channels, which prevents the influx of sodium ions into nerve cells, thereby inhibiting nerve depolarization and the propagation of action potentials.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Miller&rsquo;s Anesthesia, 9th Ed. Pg 871</span></strong></span></span></p>",
      "correct_choice_id": 4120,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20457,
      "choices": [
        {
          "id": 81789,
          "text": "<p><span style=\"font-size:12pt;\">Nasal Cannula</span></p>"
        },
        {
          "id": 81790,
          "text": "<p><span style=\"font-size:12pt;\">Simple face mask</span></p>"
        },
        {
          "id": 81791,
          "text": "<p><span style=\"font-size:12pt;\">Non-Rebreathing mask</span></p>"
        },
        {
          "id": 81792,
          "text": "<p><span style=\"font-size:12pt;\">Venturi Mask</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Identify the airway which can be used to maintain FiO2 of 0.24 to 0.60. (FMGE JAN 2023)</span></p>",
      "unique_key": "Q8692082",
      "question_audio": null,
      "question_video": null,
      "map_id": 15764038,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Venturi Mask</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Venturi mask can be used to maintain FiO2 of 0.24 to 0.60.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">A Venturi mask is an oxygen delivery device that provides a fixed concentration of oxygen to patients by mixing oxygen with room air based on the Venturi effect. It is commonly used for patients requiring controlled oxygen therapy, such as those with COPD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/25/screenshot-2024-06-25-125757.jpg\" alt=\"\" width=\"1000\" height=\"1526\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/25/screenshot-2024-06-25-125834.jpg\" alt=\"\" width=\"1000\" height=\"1398\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Venturi mask can be used to maintain FiO2 of 0.24 to 0.60.</span></p>",
      "correct_choice_id": 81792,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57516,
      "choices": [
        {
          "id": 229437,
          "text": "<p><span style=\"font-size:12.0pt;\">0.01 mg/kg (1ml/kg of 1:10,000 solution)</span></p>"
        },
        {
          "id": 229438,
          "text": "<p><span style=\"font-size:12.0pt;\">0.1 mg/kg (1ml/kg of 1:1000 solution)</span></p>"
        },
        {
          "id": 229439,
          "text": "<p><span style=\"font-size:12.0pt;\">0.001 mg/kg (1ml/kg of 1:1,00,000 solution)</span></p>"
        },
        {
          "id": 229440,
          "text": "<p><span style=\"font-size:12.0pt;\">0.5 mg/kg (1ml/kg of 1:2000 solution)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the recommended dose of adrenaline for a child during cardiac arrest ? (NEET PG 2024)</span></p>",
      "unique_key": "Q7186982",
      "question_audio": null,
      "question_video": null,
      "map_id": 15766071,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 0.01 mg/kg (1ml/kg of 1:10,000 solution)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The recommended dose of adrenaline (epinephrine) for a child during cardiac arrest is 0.01 mg/kg, using a 1:10,000 dilution. Adrenaline is a potent vasoconstrictor and inotrope, meaning it increases heart rate, myocardial contractility, and peripheral resistance, which are all necessary in a cardiac arrest situation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B: 0.1 mg/kg (1ml/kg of 1:1000 solution):</strong> This dose is incorrect for cardiac arrest and could be dangerous if administered. The 1:1000 solution of adrenaline is typically used for severe allergic reactions (anaphylaxis), not for cardiac arrest.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C: 0.001 mg/kg (1ml/kg of 1:1,00,000 solution):</strong> This dose is too low to be effective during cardiac arrest and does not match the recommended guidelines.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D: 0.5 mg/kg (1ml/kg of 1:2000 solution):</strong> This option is incorrect as it does not correspond to the recommended concentration or dose for adrenaline administration in pediatric cardiac arrest.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct dose of adrenaline for a child during cardiac arrest is 0.01 mg/kg using a 1:10,000 solution.</span></p>",
      "correct_choice_id": 229437,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/57516/Neet_Pg_Aug_2024_Anesthesia_Q_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/57516/Neet_Pg_Aug_2024_Anesthesia_Q_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 571,
      "choices": [
        {
          "id": 2280,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Both 1 and 2</span></p>"
        },
        {
          "id": 2281,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Both 3 and 4</span></p>"
        },
        {
          "id": 2282,
          "text": "<p><span style=\"color:black;font-size:12pt;\">1 only</span></p>"
        },
        {
          "id": 2283,
          "text": "<p><span style=\"color:black;font-size:12pt;\">2 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A 70-year-old male patient was undergoing laparoscopic cholecystectomy. Halfway through the surgery, a sudden drop in EtCO<sub>2</sub> to 8 mm Hg was noted. His SpO<sub>2</sub> became 90% and blood pressure dropped to 70/50 mmHg and peak airway pressure was 18 cm of H<sub>2</sub>O. What is the diagnosis?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">CO<sub>2</sub> embolism</span></li><li><span style=\"font-size:12pt;\">Severe bronchospasm</span></li><li><span style=\"font-size:12pt;\">Pneumothorax</span></li><li><span style=\"font-size:12pt;\">Single bronchus intubation</span></li></ol><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>EtCO<sub>2</sub></strong>-End-tidal carbon dioxide</span></p>",
      "unique_key": "Q9284062",
      "question_audio": null,
      "question_video": null,
      "map_id": 15763957,
      "difficulty_level": "intermediate",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. 1 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>1. CO2 embolism</strong>: During laparoscopic procedures, CO2 is used to insufflate the abdomen, creating a pneumoperitoneum. This allows for better visualization and manipulation of the internal structures. If there's a vascular injury, especially to a large vein, CO2 can enter the circulation and cause an embolism. This can lead to sudden cardiovascular collapse and a sharp drop in EtCO2, as observed in the scenario. Also, a sudden drop in oxygen saturation (SpO2) can occur due to the embolism obstructing the pulmonary vasculature. The significant drop in EtCO2, in this case, is indicative of a CO2 embolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>2. Severe bronchospasm</strong>: Bronchospasm would lead to an increase in peak airway pressure, which wasn't seen in this scenario (the peak airway pressure was 18 cm of H2O, which is within the normal range). Moreover, EtCO2 would generally be elevated in bronchospasm due to retention of CO2, not decreased as seen in the scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>3. Pneumothorax</strong>: A pneumothorax could cause a drop in SpO2 and blood pressure. However, the EtCO2 drop to 8 mm Hg in the setting of laparoscopic surgery more specifically suggests a CO2 embolism. Additionally, one would expect an increase in peak airway pressures with a tension pneumothorax.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>4. Single bronchus intubation</strong>: If the endotracheal tube is advanced too far and intubates a single bronchus, it would lead to ventilation of one lung only. This can cause a decrease in SpO2, but the sudden drop in EtCO2 as seen in the scenario isn't typical for single bronchus intubation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective :</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">A sudden and significant drop in EtCO2 during laparoscopic surgery, along with a decrease in SpO2 and blood pressure, strongly suggests a CO2 embolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Miller’s Anesthesia, 9<sup>th</sup> Ed. Pg 1879</strong></span></p>",
      "correct_choice_id": 2282,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6497,
      "choices": [
        {
          "id": 25957,
          "text": "<p><span style=\"font-size:12.0pt;\">Ofloxacin</span></p>"
        },
        {
          "id": 25958,
          "text": "<p><span style=\"font-size:12.0pt;\">Levofloxacin</span></p>"
        },
        {
          "id": 25959,
          "text": "<p><span style=\"font-size:12.0pt;\">Pefloxacin</span></p>"
        },
        {
          "id": 25960,
          "text": "<p><span style=\"font-size:12.0pt;\">Lomefloxacin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 62-year-old man with chronic liver disease is experiencing recurrent urinary tract infections. His healthcare team is considering various antibiotics, including fluoroquinolones, to treat the infection. Which of the following fluoroquinolones is not recommended for use in patients with liver disease? (NEET PG 2020)</span></p>",
      "unique_key": "Q7850447",
      "question_audio": null,
      "question_video": null,
      "map_id": 15708913,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Pefloxacin</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Pefloxacin is a fluoroquinolone antibiotic that is primarily eliminated by the liver. In patients with liver disease, pefloxacin can accumulate in the body and cause hepatotoxicity. Therefore, it is not recommended for use in patients with liver disease or hepatic impairment.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Ofloxacin</strong>: Ofloxacin is a fluoroquinolone antibiotic that is eliminated by both the liver and the kidneys. It can be used with caution in patients with liver disease, provided the dosage is adjusted according to hepatic function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Levofloxacin</strong>: Levofloxacin is another fluoroquinolone that is eliminated by both the liver and kidneys. It is generally considered safe for use in patients with liver disease, with appropriate dose adjustments based on hepatic function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Lomefloxacin</strong>: Lomefloxacin is also eliminated by both the liver and kidneys and can be used in patients with liver disease, provided that dosage adjustments are made.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Fluoroquinolones that are safe in renal failure, avoided in liver failure and not effective in UTI include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">P: Pefloxacin</span></li><li><span style=\"font-size:12.0pt;\">M: Moxifloxacin</span></li><li><span style=\"font-size:12.0pt;\">T: Trovafloxacin</span></li></ul>",
      "correct_choice_id": 25959,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1004,
      "choices": [
        {
          "id": 4012,
          "text": "<p><span style=\"font-size:12pt;\">Automated External Desynchronizer</span></p>"
        },
        {
          "id": 4013,
          "text": "<p><span style=\"font-size:12pt;\">Automated External Defibrillator</span></p>"
        },
        {
          "id": 4014,
          "text": "<p><span style=\"font-size:12pt;\">Automated Electronic Defibrillator</span></p>"
        },
        {
          "id": 4015,
          "text": "<p><span style=\"font-size:12pt;\">Automated External decompressor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Identify the device shown in the image below?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/02/screenshot-2024-07-02-153116.jpg\" alt=\"\" width=\"300\" height=\"398\"></span></p>",
      "unique_key": "Q1883147",
      "question_audio": null,
      "question_video": null,
      "map_id": 15763967,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Automated External Defibrillator</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Automated External Defibrillator (AED):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Definition:</strong> An automated external defibrillator (AED) is a portable electronic device that automatically diagnoses the life-threatening cardiac arrhythmias of ventricular fibrillation (VF) and pulseless ventricular tachycardia, and is able to treat them through defibrillation, the application of electricity which stops the arrhythmia, allowing the heart to re-establish an effective rhythm.</span></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Rapid Defibrillation:</strong> Rapid defibrillation is paramount in improving survival rates from sudden cardiac arrest due to ventricular fibrillation or pulseless ventricular tachycardia.</span></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>User-Friendly and Accessible:</strong> AEDs are made for laypersons and first responders, not just for medical professionals. They come with voice prompts and sometimes visual displays to guide the user through each step of the defibrillation process. This design makes it possible for people without extensive medical training to assist in a cardiac emergency.</span></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Self-Analyzing:</strong> An AED automatically evaluates the heart rhythm of a person in cardiac arrest. If the device detects a shockable rhythm, it will instruct the user to deliver a shock; if not, it will guide the user to continue with CPR or other appropriate interventions. This ensures that shocks are only given when necessary.</span></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Public Availability:</strong> Many public places such as airports, gyms, schools, and shopping centers have publicly accessible AEDs. Increasing the availability and visibility of AEDs in public spaces can reduce the time to defibrillation and increase survival rates from out-of-hospital cardiac arrest.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Automated External Desynchronizer: </strong>This term is incorrect and not associated with any known medical device.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Automated Electronic Defibrillator: </strong>This term is incorrect and not associated with any known medical device.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Automated External Decompressor: </strong>This term is incorrect and not associated with any known medical device.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">An Automated External Defibrillator (AED) is a crucial device for rapidly diagnosing and treating life-threatening cardiac arrhythmias through defibrillation, especially designed for use by laypersons and first responders to increase survival rates in cases of sudden cardiac arrest.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Miller’s Anesthesia, 9<sup>th</sup> Ed. Pg</strong> <strong>2537</strong></span></p>",
      "correct_choice_id": 4013,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ImageBased",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4529,
      "choices": [
        {
          "id": 18092,
          "text": "<p><span style=\"font-size:12.0pt;\">Ligamentum flavum</span></p>"
        },
        {
          "id": 18093,
          "text": "<p><span style=\"font-size:12.0pt;\">Dura mater</span></p>"
        },
        {
          "id": 18094,
          "text": "<p><span style=\"font-size:12.0pt;\">Arachnoid mater</span></p>"
        },
        {
          "id": 18095,
          "text": "<p><span style=\"font-size:12.0pt;\">Pia mater</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient presented with headache, vomiting, and fever. Meningitis was suspected. While performing a lumbar puncture, which is the last structure you will pierce just before entering the lumbar cistern? (NEET PG 2021)</span></p>",
      "unique_key": "Q1138371",
      "question_audio": null,
      "question_video": null,
      "map_id": 15764017,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Arachnoid mater</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The arachnoid mater is the last structure you will pierce while performing a lumbar puncture.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Layers pierced while performing lumbar puncture/spinal anesthesia (subarachnoid space) from outside to inside are:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Skin</span></li><li><span style=\"font-size:12.0pt;\">Subcutaneous tissue</span></li><li><span style=\"font-size:12.0pt;\">Supraspinous ligament</span></li><li><span style=\"font-size:12.0pt;\">Interspinous ligament</span></li><li><span style=\"font-size:12.0pt;\">Ligamentum flavum</span></li><li><span style=\"font-size:12.0pt;\">Dura mater</span></li><li><span style=\"font-size:12.0pt;\">Arachnoid mater</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Upon piercing the arachnoid mater, you enter the subarachnoid space (lumbar cistern), where cerebrospinal fluid (CSF) is collected during a lumbar puncture.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Ligamentum flavum: </strong>The ligamentum flavum is a strong ligament that connects the laminae of the vertebrae. It is pierced before the dura mater during a lumbar puncture.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Dura mater: </strong>The dura mater is a tough outer meningeal layer that is pierced before the arachnoid mater during a lumbar puncture.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pia mater: </strong>The pia mater is the innermost meningeal layer that directly covers the spinal cord. It is not pierced during a lumbar puncture.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective :</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The arachnoid mater is the last structure pierced before entering the lumbar cistern during a lumbar puncture.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/07/untitled-961.jpg\" alt=\"\" width=\"300\" height=\"270\"></span></p>",
      "correct_choice_id": 18094,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4531,
      "choices": [
        {
          "id": 18100,
          "text": "<p><span style=\"font-size:12.0pt;\">CPR with 20% intralipid</span></p>"
        },
        {
          "id": 18101,
          "text": "<p><span style=\"font-size:12.0pt;\">CPR with sodium bicarbonate</span></p>"
        },
        {
          "id": 18102,
          "text": "<p><span style=\"font-size:12.0pt;\">CPR with dobutamine</span></p>"
        },
        {
          "id": 18103,
          "text": "<p><span style=\"font-size:12.0pt;\">CPR with calcium</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young male patient was given regional block with 0.25% bupivacaine for a minor surgical procedure.&nbsp;Shortly after the injection, the patient suddenly became unresponsive and the pulse was not recordable. Which of the following would be the best course of management for this patient? (NEET PG 2021)</span></p>",
      "unique_key": "Q8068662",
      "question_audio": null,
      "question_video": null,
      "map_id": 15764044,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) CPR with 20% intralipid</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The scenario described involves a young male patient who received a regional block with 0.25% bupivacaine for a minor surgical procedure and subsequently became unresponsive with an unrecordable pulse.</span></li><li><span style=\"font-size:12.0pt;\">&nbsp;These are concerning signs of Local Anesthetic Systemic Toxicity (LAST), which can occur when local anesthetic drugs like bupivacaine enter the systemic circulation.</span></li><li><span style=\"font-size:12.0pt;\">The best course of management for this patient is as follows:</span></li><li><span style=\"font-size:12.0pt;\">This is the correct choice. Intralipid is a lipid emulsion used as the antidote for LAST.</span></li><li><span style=\"font-size:12.0pt;\">It works by sequestering the local anesthetic drug in the lipid phase and reducing its toxic effects on the cardiovascular and central nervous systems.</span></li><li><span style=\"font-size:12.0pt;\">&nbsp;CPR (Cardiopulmonary Resuscitation) should be initiated, and 20% intralipid should be administered intravenously to treat LAST.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. CPR with sodium bicarbonate</strong>: Sodium bicarbonate is not the first-line treatment for LAST. While it can be used to treat certain cardiac arrhythmias caused by local anesthetic toxicity, it does not directly counteract the toxic effects on the central nervous system and is not as effective as intralipid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. CPR with dobutamine</strong>: Dobutamine is a medication used to increase cardiac output and blood pressure in some situations, but it is not the primary treatment for LAST.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. CPR with calcium:</strong> Calcium does not reverse the toxic effects of local anesthetic systemic toxicity. Therefore, it is not the appropriate treatment for this situation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">When a patient experiences LAST with signs of cardiovascular collapse and central nervous system toxicity, the recommended treatment is CPR (if necessary) along with the administration of 20% intralipid intravenously, as it helps to reverse the toxic effects of the local anesthetic and improve the patient's condition.</span></li><li><span style=\"font-size:12.0pt;\">Drug of choice for treatment of LAST – 20% Intralipid IV</span></li></ul>",
      "correct_choice_id": 18100,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}